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3. Abbreviations 
AM = anterior meningocele
AP = anteroposterior
CI = confidence interval
CT = computed tomography
CTA = computed tomography angiography
CWD = circle-wall distance 
DE = dural ectasia
DSD = dural sac diameter
DSR = dural sac ratio
FBN1 = human gene encoding the protein fibrillin 1
HRCT = high resolution computed tomography
ICC = inter class correlation coefficient
MASS syndrome/MASS phenotype = requires at least two of the following manifestations: 
myopia, mitral valve prolapse, aortic root diameter at the upper limits of normal for body size,
skin stretch marks (striae), and minor skeletal features of Marfan syndrome
MDCT = multi detector computed tomography
MFS = Marfan syndrome
MRI = magnetic resonance imaging
MRA = magnetic resonance angiography
PA = protrusio acetabuli
PACS = picture archiving and communication system
ROC = receiver operating characteristic
R-R interval = interval between heartbeats
SD = standard deviation
TE = echo time
TEE = transesophagial echocardiography
TGFBR1  KXPDQJHQHHQFRGLQJWKHSURWHLQWUDQVIRUPLQJJURZWKIDFWRUȕUHFHSWRU
TGFBR2 = human gene encoding the protein transforming growth factor, ȕUHFHSWRU
TR = repetition time
VBD = vertebral body diameter, measured at mid-corpus level
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4. Introduction and background 
Marfan syndrome (MFS) is an autosomal dominant disorder of connective tissue. Life 
expectancy is generally reduced in MFS patients, mainly due to progressive dilation and 
dissection of the aorta. Other manifestations include dislocation of the lens and skeletal 
deformities. Early diagnosis, follow-up, and treatment are important to prolong life and 
reduce disability. 
"Radiological Imaging in the Investigation of Marfan Syndrome" is a spin-off project derived 
from the “Norwegian Marfan Study”, a collaborative project between the Norwegian user 
organisation (“The Norwegian organisation for Marfan Syndrome (MFS) and other Marfan-
like disorders”), TRS - a national resource center for seven rare disorders, and co-workers 
from different hospital departments, representing specialists in thoracic and vascular surgery, 
cardiology, ophthalmology, radiology, medical genetics, clinical chemistry and physical 
medicine and rehabilitation at Oslo University Hospital.
The main project was initiated by Svend Rand-Hendriksen, MD, PhD, who aimed to explore 
the MFS genotype and phenotype in accordance with the diagnostic system used at that time, 
the “Ghent 1 criteria” (1). He also intended to “investigate the prevalence of the phenotypic 
features and their consequences for perceived health-related quality of life” (2).
In the “Norwegian Marfan Study” all patients were assessed for all parts of the diagnostic 
system, the “Ghent 1” criteria, by the same group of physicians (Table 1). Medical imaging 
technologies have become immeasurably important tools in many medical disciplines; so also 
in the diagnostic process of the pleiotropic disorder MFS. The need for radiological imaging 
examinations was the starting point of this project. Radiological imaging according to the 
Ghent criteria is required to assess dural ectasia, scoliosis, spondylolisthesis, protrusio 
acetabuli, calcification of the mitral annulus, pulmonary artery dilatation, and apical blebs in 
the lungs. In addition radiological imaging gives better visualization of the aortic arch and 
descending aorta than echocardiography. Different radiological methods have been used in 
the diagnostic process of MFS, and there is an ongoing discussion on which methods are 
necessary to include in this process. Through this thesis, I hope to participate in the debate on 
which radiological methods are important in the diagnostic process of MFS. 
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Table 1. Diagnostic criteria for Marfan syndrome (MFS) according to the Ghent 1 nosology
Major criteria Criterion for involvement
Skeletal Requires four of the eight manifestations listed 
below
Manifestations
x Pectus carinatum
x Pectus excavatum requiring surgery
x Reduced upper to lower segment 
ratioௗௗRUDUPVSDQWRKHLJKWUDWLR
greater than 1.05
x Wrist and thumb signs
x Scoliosis ofௗ!ௗRUVSRQG\OROLVWKHVLV
x Reduced extension at the elbows (< 170°)
x Medial displacement of the medial 
malleolus causing pes planus
x Protrusio acetabuli of any degree
Requires two of the eight manifestations in the left 
column or one manifestation plus two of the four minor 
criteria listed below
Minor criteria
x Pectus excavatum of moderate severity
x Joint hypermobility (Beighton scoreௗௗ
x Highly arched palate with crowding of teeth
x Facial appearance (dolicocephaly, malar 
hypoplasia, enopthalmos, retrognathia, down-
slanting palpebral fissures)
Ocular x Ectopia lentis Requires two of the following three minor criteria
Minor criteria
x Abnormally flat cornea (< 41,5 dioptres)
x Increased axial length of the ocular globe 
(>23,5 mm)
Hypoplastic iris or ciliary body
Cardiovascular x Dilatation of the ascending aorta with or 
without aortic regurgitation and involving 
at least the sinuses of Valsalva
x Dissection of the ascending aorta
Requires the presence of at least one major criterion or 
one minor criterion
Minor criteria
x Mitral valve prolapse with or without mitral valve 
regurgitation
x Dilatation of the main pulmonary artery in the 
absence of valvular or peripheral pulmonic 
stenosis or any other obvious cause below the age 
of 40 years
x Calcification of the mitral annulus before the age 
of 40 years
x Dilatation or dissection of the descending thoracic 
or abdominal aorta below the age of 50 years
Pulmonary None Requires at least one minor criterion
Minor criteria
x Spontaneous pneumothorax
x Apical blebs
Skin and 
integument
None Requires at least one minor criterion
Minor criteria
x Striae atrophicae (stretch marks) not associated 
with marked weight changes, pregnancy or 
repetitive stress
x Recurrent or incisional hernia
Dura mater x Lumbosacral dural ectasia None
Genetic x Having a parent, child or sib who meets 
these diagnostic criteria independently
x Presence of a mutation in FBN1 known to 
cause the Marfan syndrome
x Presence of a FBN1 haplotype around 
FBN1, inherited by descent, known to be 
associated with unequivocally diagnosed 
Marfan syndrome in the family
None
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4.1  Historical background for the MFS diagnosis 
In 1896, the Parisian pediatrician Antoine Marfan, described Gabrielle P, a 5 year old girl who 
was unusually tall, and had long and slender fingers and toes. This was the first description of 
the syndrome which was later named after him (3). However, whether the girl actually was 
affected by Marfan syndrome or not, has never been clarified.
In 1956, MFS was described by Victor A. McKusick as an example of “heritable disorders of 
connective tissue” (4), and in 1979 criteria for MFS were proposed by Pyeritz and McKusick
(”The Marfan syndrome: diagnosis and management”) (5). A committee of international 
consultants suggested standards for the diagnosis of common heritable disorders of 
connective tissue in 1986, also including MFS (the Berlin nosology) (6).
In 1991, a mutation in the gene encoding for fibrillin (FBN1) was reported as the cause of 
MFS for the first time (7). One hundred years after the first description of this disease, in 
1996, the revised criteria for MFS (Ghent 1) were presented by DePaepe et al. in the article 
“Revised diagnostic criteria for the Marfan syndrome” (1) (Table 1).
In 2010, the most recent nosology for MFS was published by Loeyz et al. in the paper “The 
revised Ghent nosology for the Marfan syndrome” (8) (Ghent 2). This nosology will be 
briefly presented only, since all examinations and evaluations in the “Norwegian Marfan 
study” were performed according to Ghent 1.
4.2  Etiology 
The only gene mentioned in the Ghent 1 criteria for MFS is the FBN1 gene at 15q21 (1).
There are, however, found numerous different mutations in this gene in different MFS 
patients, and it is said that many families carry their own private mutation (9;10). FBN1
mutations are found in individuals fulfilling the Ghent 1 criteria for MFS as well as in persons
not fulfilling the Ghent 1 criteria (10;11). FBN1 mutations can lead to a variety of conditions 
that are related to MFS, including the MASS phenotype (myopia, mitral valve prolapse, aortic 
dilatation, skin and skeletal involvement), familial ectopia lentis, familial Marfan-like habitus, 
familial thoracic aortic aneurysms and dissections, Weill–Marchesani syndrome and 
Shprintzen–Goldberg syndrome.
All persons exhibiting an FBN1 mutation independent of whether they fulfill the Ghent 
criteria or not are said to belong to a “Type 1 fibrillinopathy” (12). Hundreds of different 
mutations have been identified till now, and according to Stheneur et al. the great majority 
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(79.1%) of all FBN1
In addition to the finding of different fibrillin 1 mutations in Ghent positive patients, 
mutations in TGFBR1 and TGFBR2 have recently been reported in individuals fulfilling the 
Ghent 1 criteria (2;14;15). These patients (previously given the diagnosis MFS 2) are now 
defined as having Loeys-Dietz syndrome.
mutations described today (more than 1750, data not published) come 
from the European laboratories and especially Western Europe (13).
Mutations of FBN1 may cause abnormal microfibrils, and either alone or in association with 
elastin in the elastic fibers, these abnormal microfibrils can induce fragmentation of elastic 
fibers, and impairment of elastic tissue homeostasis. Manifestations in the connective tissue 
like ectopia lentis, protrusio acetabuli and dural ectasia can be explained by these changes in 
the elastic tissue.
Mutation of FBN1 also affects the regulation of tissue growth factor signaling (TGF-ȕ
signaling), which is related to the pathogenesis of bone overgrowth, pulmonary 
manifestations, valve changes, and aortic dilatation (16-19). Research on mouse models has
revealed that dysregulation in TGF-ȕVLJQDOLQJLVLPSRUWDQWLQWKHJHQHVLVRIGLIIHUHQW
developmentally and acquired states of elastic tissue deficiency in MFS. Part of the control of 
fibrillin-1 over connective tissue homeostasis is mediated by limiting activation of TGF- ȕ.
Fibrillin-1–deficient lung tissue has been shown to have increased presence of activated TGF-
ȕ (16).
4.3  Manifestations and Diagnosis 
As already stated, MFS includes manifestations in many organ systems, with diverse features 
in different organs arising from a single mutation. There are several different phenotypes of 
this disease, and in the “Norwegian Marfan study” 87 patients fulfilled the Ghent 1 criteria in 
56 different ways.
In the cardiovascular system, progressive dilatation of the aorta, usually maximal at the sinus 
of Valsalva is associated with aortic valve incompetence, and aortic dissection or rupture. The
aortic pathology represents the main cause of morbidity and mortality in Marfan syndrome
(20). Other cardiovascular signs are mitral valve prolapse, with or without regurgitation,
descending aorta dissection, and dilatation of the main pulmonary artery. Dilated 
cardiomyopathy in the absence of severe valvular dysfunction may also be found (21).
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In the musculoskeletal system, tall stature, and long arms, legs, fingers and toes are common,
(dolichostenomelia, arachnodactyly). Pectus excavatum or carinatum, scoliosis of the 
vertebral column, and protrusio acetabuli are also among the features.
In the ocular system, ectopia lentis is the most serious affection, but myopia and retinal 
detachment may also be present.
In the lungs, apical blebs may be found, and pneumothorax is a possible complication to this.
In the skin and integument, striae not related to pregnancy, and hernias are seen. In the 
nervous system, dural ectasia is found in a high percentage of patients.
The diagnosis of MFS is based on the identification of a combination of the manifestations
listed in Table 1. Confirmation of the diagnosis in an individual requires the presence of 
major clinical manifestations in at least two organ systems associated with involvement of a 
third organ system. In the presence of an FBN1 mutation known to cause MFS, or in relatives 
of an affected proband, major involvement of one organ system and involvement of a second 
organ system confirms the diagnosis (1).
In the revised Ghent criteria published in 2010 (Ghent 2 criteria) more weight is given to 
aortic root aneurysm/dissection and ectopia lentis. The combination of ectopia lentis and 
aortic root enlargement/dissection are sufficient for diagnosis of MFS alone. Features in the 
cardiovascular, ocular, skeletal, dura, integument, and skin, contribute to the diagnosis as 
systemic signs. Some findings are weighted more than they were in the Ghent 1 criteria, for 
instance protrusion of the acetabulum; others are weighted less, for instance dural ectasia. 
Pulmonary artery dilatation is not counting as a sign of MFS according to these new criteria
(8).
The Ghent 2 nosology was published subsequent to the time when we completed clinical
examinations and most of the analysis of this study. Our study population was diagnosed 
according to the Ghent 1 nosology.
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4.4  Epidemiology 
4.4.1 Prevalence  
The prevalence of MFS is difficult to estimate because the reported prevalence is dependent 
on the inclusion criteria being used for the diagnosis. Changing diagnostic systems have 
entailed that some patients fulfilling the diagnosis according to one system, do not fulfill 
another. Radonic et al. examined patients for both Ghent 1 and Ghent 2 criteria, and some of 
the patients fulfilled the Ghent 1 but not the Ghent 2 criteria (22). Some of the signs for MFS 
also do not develop until adolescence or adulthood, and this makes the diagnosis even more 
difficult to assess.
A study in Scotland published in 1994, found a minimal prevalence of MFS to be 1:14,217
(23). In 2007 von Kodolitsch et al. reported an estimated prevalence for MFS of 1 in 5,000
individuals (24), while in 2008 Rybczynski et al. reported a prevalence of “MFS and Marfan-
like syndromes” to be 7 in 100,000 people (25).
Men and women are said to be affected equally often by MFS (24), and approximately 25% 
of cases are caused by de novo mutations (26). Gray found that 26.7% of their MFS patients 
were de novo mutations (23).
4.4.2  Survival 
Mean age at death (± SD) was found to be 41 (± 18) years in a study by Silverman et al.,
published in 1995 (27). This was significantly increased compared with mean age at death in 
1972 which was 32 (± 16) years (p = 0.0023) (28).
4.4.3  Treatment  
Treatment decisions concerning MFS depend on manifestations in the single patient. Marfan 
syndrome and Marfan-related syndromes are diseases which may involve several organ 
systems and therefore require coordinated medical care from specialists in different areas. 
Complete management requires team work, including a geneticist, cardiologist, 
ophthalmologist, orthopedist, and cardiothoracic surgeon, and a radiologist.
When the maximum diameter of the aorta exceeds 5.0 cm, surgical repair is needed. When the 
rate of increasing aortic diameter approaches 1.0 cm per year, or progressive aortic 
regurgitation occurs, surgery is also needed. Patients with a family history of early dissection 
of the aorta may need more aggressive therapy (7). In the latest guidelines for treatment of 
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patients with thoracic aortic disease, it is recommended that a ratio between the maximal 
cross-sectional area in square centimeters of the ascending aorta or root and the patient’s 
height in meters should be used; if this ratio exceeds 10, surgical repair is reasonable. This is 
because shorter patients have dissection at a smaller aortic size, and 15% of patients with 
Marfan syndrome have dissection at an aortic diameter less than 5.0 cm (29).
Use oIȕ-adrenergic blockade to reduce hemodynamic stress on the proximal aorta in Marfan 
syndrome was first suggested in 1971 (21), and in a study published in 2006 by Ladoceur et 
al., where treatment with ȕ-adrenergic blockade was tried on children, there was a trend 
towards lower mortality, less preventive surgery for aortic dilatation, and fewer cases of 
dissection (30).
Losartan is an angiotensin II type 1 receptor blocker, and this substance was found to be 
potentially useful in MFS because it lead to antagonism of TGF-ȕLQDQLPDOPRGHOVRI
chronic renal insufficiency and cardiomyopathy (31). In a small observational study using 
losartan in children with severe MFS, preliminary results on aortic dilatation inhibition have 
been promising (32). The COMPARE study (COzaar in Marfan Patients Reduces aortic 
Enlargement) is an open-label, randomized, controlled trial with blinded end-points. 
Treatment with losartan will be compared with no additional treatment after 3 years of follow-
up (22).This has yet to be done.
4.5  Radiology in MFS 
To image all the “radiological” features of MFS according to the Ghent 1 criteria, we did the 
following examinations.
x MRI (or CT) to assess the ascending aorta (examined also by echocardiography), 
descending aorta and pulmonary artery
x MRI (or CT) to assess dural ectasia and spondylolisthesis in the lumbosacral region 
x scout view from CT to assess scoliosis 
x CT to assess protrusio acetabuli
x HRCT to assess apical blebs in the lungs, and calcification of the mitral annulus
15 
 
 
4.5.1  Imaging of the ascending aorta and pulmonary artery 
The ascending aorta is an important structure to examine in this patient group to verify or 
exclude dilatation and dissection, and different methods have been used in the diagnostic 
process.
Transthoracic echocardiography is commonly used in the examination of the ascending aorta. 
In 1979 Pyeritz and McKusick wrote: “Echocardiography has greatly enhanced the detection 
of the cardiovascular abnormalities, and improved both diagnosis and management of MFS”
(33). Weaknesses of this method are high dependability on appropriate acoustic window and 
skilled operator, and inability to visualize the descending aorta. The descending aorta may be 
imaged in detail with transesophagial echocardiography (TEE), but this is a more invasive and 
less available method.
Today, contrast-enhanced computed tomography (CT) is the most commonly used 
radiological method for imaging of the aorta. CT imaging has been used in many years as a 
tool for the diagnosis of thoracic aortic diseases, and it has the advantages of being available 
in most hospitals. This method is exact in displaying details from aorta, and the examination 
is executed in a short time. CT of the ascending aorta as opposed to echocardiography can 
depict both thoracic aortic disease, and other diseases that can mimic aortic disease. 
Especially after intervention on the aorta CT is preferred to detect asymptomatic 
postprocedural leaks or pseudo aneurysms, because of the presence of metallic closure 
devices and clips (29). Historically CT images were generated in the axial or transverse plane, 
orthogonal to the long axis of the body. However, non-gated axial CT examinations of the 
chest do not take into account the obliquity of the aorta, nor the systolic expansion or the non 
axial movements during the cardiac cycle (34). Modern multi detector CT (MDCT) scanners
have revolutionized medical imaging. Imaging with isovolumetric voxels enables 
reformations in any plane without loss of spatial resolution, and combined with ECG-trigging, 
true short axis depiction of any part of the aorta or pulmonary artery is possible without 
pulsatory artefacts, allowing a more exact measurement of either systolic or diastolic vessel 
diameter or vessel cross-sectional area. Vessel tortuosity is easily shown by three-dimensional 
(3D) reconstructions. 
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MR imaging is a good alternative to CT in imaging of the aorta and pulmonary artery. Being 
free of ionizing radiation, it should be the method of choice in children and when repeated 
examinations are indicated, especially in young patients. Drawbacks of the method as 
compared to echocardiography and CT are cost and less availability. There are several MR 
methods available for imaging of the aorta and pulmonary artery. ECG-triggered two-
dimensional (2D) “black blood imaging” using non-enhanced spin-echo (SE) or turbo spin-
echo (TSE) pulse sequences may be performed with or without breath-holding (to eliminate 
respiratory artifacts). These 2D techniques have the advantage of showing the vessel wall, 
including vessel wall thickening due to inflammation. 3D gradient-echo (GRE) techniques are 
generally faster and allow true short axis reformations of vessel lumina or 3D angiographic 
reconstructions. Both contrast-enhanced and non-enhanced methods are available. Contrast-
enhanced 3D MR angiography (MRA) with breath-hold but without ECG-trigging, is superior 
in visualizing the entire aorta with side-branches, while the somewhat slower non-enhanced 
3D steady state techniques such as trueFISP with ECG-trigging and respiratory gating with 
navigator echo, allow high resolution short axis depiction of the great thoracic vessels free of 
pulsatory blurring. 
According to a publication in 1996, CT had a sensitivity and specificity of 100% for 
identification of aortic dissection, while transesophageal echocardiography (TEE) and MR 
imaging both had a sensitivity of 100% and specificity of 94% (35). The authors concluded 
that CT, TEE and MR imaging are all valuable methods in the detection of thoracic aortic 
dissection. However, they found that for the assessment of the supraaortic arterial branches, 
CT was superior (35).
In 2005, Milewicz et al. claimed that “the initial evaluation of an individual with MFS should 
include an echocardiogram to assess the ascending aorta and cardiac valves” (36). They 
emphasized, however, that the results of echocardiography are dependent on the sonographer 
and the equipment, and that spiral thin-slice CT angiography (CTA) or MR angiography 
(MRA) with 3D reconstructions are precise, and should be used if echocardiography does not 
provide good quality images of the aorta. They recommended routine CTA or MRA of the 
entire distal aorta if the descending thoracic aorta is large or has dissected.
In 2010, Hiratzka et al. (“Guidelines for the Diagnosis and Management of Patients With 
Thoracic Aortic Disease 2010”) still recommended echocardiography as the imaging modality
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of choice as a start in the diagnostic process of the cardiovascular system in proposed MFS
patients, and also in the follow up of the aortic sinus of Valsalva if the diameter is stable.
They stress, however, that definitive identification or exclusion of thoracic aortic disease 
requires dedicated aortic imaging, and that selection of the most appropriate imaging study 
may depend on patient-related factors like hemodynamic stability, renal function, contrast 
allergy, and institutional capabilities. Transthoracic echocardiography has according to 
Hiratzka et al. a sensitivity of 77% to 80%, and a specificity of 93% to 96% for identification 
of proximal aortic dissection (29).
The Ghent 1 criteria from 1996 stated that echocardiography, CT or MRI may all be used to 
diagnose dilatation of the aortic root or pulmonary artery diameter, while dissection should be 
documented by contrast angiography, TEE, CT or MRI (1). English-language reports on the 
diagnosis of thoracic aortic dissection by TEE, helical CT, or MRI were identified from 
electronic databases by Shiga et al., 2006. Sixteen studies involving 1139 patients were 
selected. Sensitivity, specificity, and positive and negative likelihood ratios were pooled in a
random-effects model. Pooled sensitivity (98%-100%) and specificity (95%-98%) were 
comparable between the three imaging techniques (37).
For both contrast-enhanced CT, conventional angiography and MRI consideration should be 
given to patients with reduced renal function. Iodinated contrast media injection in CT
examinations and conventional angiography may induce nephropathy. Gadolinium based 
contrast agents, used for MRA, imply a risk of nephrogenic systemic fibrosis (29).
4.5.2  Imaging of the lumbosacral column and dural sac 
Dural ectasia (DE) is a major criterion for MFS in the Ghent 1 nosology, and is one of the 
systemic signs of Ghent 2. It is present in a high percentage of patients with MFS. Several 
articles have been published on how to diagnose this feature.
Conventional radiography was the first method where signs of DE could be found, and as 
early as in 1958, Nelson et al. reported posterior scalloping seen on a conventional radiograph 
of the lumbar region of an MFS patient; he stated that “this widening of the spinal canal is 
different from other causes of spinal canal enlargement because it has different stigmata, and 
absence of neurological abnormalities”(38). In 1989, Janjua MZ and Muhammad F measured 
the vertebral body diameter and the estimated dural sac diameter on sagittal, conventional
18 
 
radiographs in normal persons, and calculated the proportion between these measurements, 
the C/B (canal/vertebral body) ratio. They found that the ratio varied between 1/2 and 1/5, and 
that a ratio >1/2 indicated a widened dural sac and <1/5 would be conclusive of stenosis (39).
In 2003, Oosterhof et al. used this article as their reference for a ratio calculated from the 
proportion between the vertebral diameter and the dural sac diameter, the dural sac ratio,
(DSR), measured on sagittal MR images. An increased DSR was used as a sign of DE (40).
Since the publication of Oosterhof´s article several papers have used DSR as a feature of DE, 
including paper I and II in this thesis.
Most recent papers on DE have used either CT or MR imaging for assessment of this feature. 
However, conventional radiography has been published as a plausible method for detection of 
DE by some authors also the last years (41;42).
Myelography is another possible method to visualize DE. Myelography was introduced in the 
early nineteen forties, first with air (as a negative x-ray contrast medium) injected in the 
subarachnoid space, and later with positive contrast media, first with oil based contrast media, 
and later with water-soluble substances injected into the subarachnoid space. The oil based 
contrast media and ionic water-soluble contrast media were reported to give epileptic activity 
and adhesive arachnoiditis. Non-ionic iodine contrast medium was introduced in the early 
nineteen seventies, and this gave much less side effects (43). Myelography visualize the dural 
sac much better than does conventional radiography, which only shows a projection of the 
bony canal. Injection of contrast agents into the subarachnoid space, also non-ionic water-
soluble substances, does however include a risk of complications.
Compared to conventional radiography, MRI and CT give considerably more information on
the dural sac, and compared to myelography these methods in general include no contrast 
medium injection into the subarachnoid space. In 1983, Fishman et al. published an article 
where CT was performed in 5 MFS patients for examination of the lumbar spine and sacrum, 
and DE was found (44). Since then a number of articles about MFS have presented methods
on how to assess DE by using conventional x-ray films, CT, and MR imaging, but no gold 
standard for the diagnosis of DE has emerged (40;45-52). Compared to CT, MRI is superior in 
depicting the soft tissues of the spinal canal, including the dural sac and dural sac herniations.
Showing also bony scalloping, it may therefore be considered the best method in the 
diagnosis of DE.
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4.5.3  Imaging of scoliosis 
“Scoliosis > 20 degrees or spondylolisthesis” is one of the eight manifestations that may 
contribute to a major skeletal criterion in the Ghent 1 criteria. Scoliosis is an abnormal side-
to-side curve of the spine with associated vertebral rotation, that affects as many as 4% of all 
adolescents (53). The scoliosis curve should optimally be imaged in a way that shows the 
effect of gravity on the curve’s magnitude, i.e. with the patient erect. Also useful in assessing 
scoliosis in patients, are posteroanterior or anteroposterior side-to-side bending images (53).
Spondylolisthesis is depicted with conventional radiography and CT, and may also be visible 
on MRI. 
4.5.4  Imaging of the hips 
Protrusio acetabuli (PA) was counted as a one of eight skeletal manifestations for MFS in the 
Ghent 1 nosology, and is assigned a systemic feature for the disease in Ghent 2. PA is found 
in quite a high proportion of MFS patients, varying in different studies based on study group 
and method of assessment. PA is an inward protrusion of the acetabulum as a rounded mass 
into the pelvis (54), and is seen in different disorders including primary idiopathic cases and 
secondary to neoplastic, infectious, metabolic, inflammatory, traumatic, congenital and 
genetic disorders (55).
Radiographic criteria for PA include the acetabular line abnormally positioned, a center-edge 
angle (CEA) of Wiberg of > 40° (Steel’s method, CEA > 50°) (Fig. 1) and crossing of the 
“teardrop” by the ilioischial line (56;57). According to Armbuster et al., “the diagnosis of 
protrusio acetabuli is warranted if the acetabular line projects medial to the ilioischial line by 
3 mm or more in men and by 6 mm or more in women (57) (Fig. 1).
Figure 1. AP radiograph of left hip with protrusio 
acetabuli showing the acetabular line projecting 
medial to the ilioischial line by more than 6 mm 
(double arrow). The center-edge angle is 75º. 
Eighteen-year-old male patient.
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Based on the various methods for assessing PA in conventional radiographs, authors have 
reported different prevalences of PA. Sponseller et al. (58) found that 16% of MFS patients 
had PA according to the Armbuster method (57), and 27% using Steel´s method (59). Yule et 
al. found a prevalence of 60% in their population of MFS patients using Kulman´s method for 
PA, which is a combination of an abnormally positioned acetabular line and either the center-
edge angle of Wiberg GHJUHHVRUFURVVLQJof the teardrop by the ilioischial line (60).
 
PA has mostly been examined by conventional radiography, and the varying results in 
different studies illustrate the problems with this method. In the article “A new tilt on pelvic 
radiographs: a pilot study”, Richards et al. discuss how the different methods will give 
different results depending on the degree of pelvic tilt (61).
MRI has been advocated as a modality for examining PA in an article by Chen et al. (62), and 
their method for assessment of PA is further studied in our article “CT of the hips in the 
investigation of protrusio acetabuli in Marfan syndrome. A case control study” (paper III).
Both MR and CT can give detailed sectional images of the hips, and direct depiction of 
acetabular protrusion is not hampered by changes in pelvic tilt. CT is superior to MR in 
visualizing cortical bone, and although not free of ionizing radiation, high-quality CT of bony 
structures may be performed with low radiation doses.
4.5.5  Imaging of the thoracic cage and lungs 
Emphysematous air filled expansions or blebs have been found in MFS patients, and are 
counted as features of the disease in the Ghent 1 nosology (Fig. 2). In the revised criteria for 
MFS from 2010 (Ghent 2), sole emphysematous blebs in the lungs do not count as features of
MFS, but spontaneous pneumothorax is still reckoned a sign of MFS. Large blebs, especially 
in the apical part of the lungs can cause spontaneous pneumothorax. Abnormalities of the 
thoracic cage such as pectus excavatum and/or carinatum are also present in many MFS 
patients, and are features for MFS in Ghent 1 and 2 (Fig. 3).
Conventional radiography of the chest has been used to examine the heart, lungs and thoracic 
cage for more than 100 years, and is still the most commonly used method for chest imaging.
CT gives, however, a much more detailed picture of the thoracic cage, and different methods 
of CT (for instance CT angiography, CTA, or high resolution CT, HRCT) are used for 
different indications.
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HRCT is a special application of computed tomography where imaging parameters are chosen 
to maximize spatial resolution, and this method is excellent for evaluation of the lung 
parenchyma. HRCT scanning is a valuable device allowing identification of the presence, 
extent and severity of interstitial lung disease (63). A narrow slice width (usually 1–2 mm) is 
used together with high spatial resolution image reconstruction algorithm. In addition, the 
field of view is minimized to make each pixel small.
Figure 2. HRCT of MFS patient with
emphysematous blebs in the left lung, and 
centrilobular emphysema in especially the right 
lung.
Figure 3. HRCT of MFS patient with pectus 
excavatum and aortic valve replacement.
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5. Aims of the study  
General aims were:
To explore the prevalence of different manifestations of Marfan syndrome by using 
radiological methods in the investigation of this disease. To evaluate different imaging 
methods in each organ system examined by radiological methods. 
Specific aims were:
1. To explore the phenotype, the prevalence of each ‘major criterion' and ‘organ 
involvement' through a prospective and complete investigation of all features of the Ghent 
1 criteria in an adult group of patients with a proven diagnosis of MFS (paper I).
2. To establish the prevalence of dural ectasia (DE) in an adult population fulfilling the 
Ghent 1 criteria for MFS, and to assess definitions of DE by MR or CT examinations
(paper II).
3. To establish the prevalence of protrusio acetabuli (PA) in adults fulfilling the Ghent 1
criteria for MFS by using CT examinations (paper III).
4. To establish the prevalence of pulmonary artery dilatation in MFS by MRI or CT, to 
correlate diameter of the vessel with aortic disease, and explore predictors of pulmonary 
artery dilatation in MFS (paper IV).
6. Materials and methods 
6.1  Study population 
The “Norwegian Marfan study” was a cross-sectional study of adults with presumed MFS 
living in Norway. The study patients were recruited either by an advertisement requesting 
adult MFS patients to participate (Journal of the Norwegian association for MFS and MFS-
like disorders), by a letter sent to adults (> 18 years) registered as having MFS in a national 
database of MFS patients (National Resource Center for Rare Disorders, Sunnaas
Rehabilitation Hospital), or through an invitation to patients suspected of having MFS, 
distributed by the  Department of Thoracic and Cardiovascular Surgery, Rikshospitalet, Oslo 
University Hospital.
One hundred and nine patients gave informed consent to participate, but only 105 attended the 
whole study. The 105 patients consisted of 67 women aged 20–69 years, mean 41.2 (SD 13.6)
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years, and 38 men aged 19–62 years, mean 35.1 (SD 11.3) years. Of the 105 study patients 90 
had been given the diagnosis of MFS previously, and 15 were suspected of having MFS.
The present substudy "Radiological Imaging in the Investigation of Marfan Syndrome" also 
comprises two control populations. In our assessment of dural ectasia (paper II), control 
subjects were chosen from the pool of patients in the radiologic archive (PACS) of the 
Department of radiology, Oslo university hospital, on the basis of the following criteria: sex-
and age-matched asymptomatic persons with respect to the lumbosacral spine and without any 
known connective tissue disease or compression fractures, screened with MR imaging for 
malignancy in the lumbosacral spine, but with no evidence of malignant disease in this area. 
The controls included 101 subjects, 64 women aged 18-65 years, mean 39.6 (SD 12.9) years
and 37 men aged 18–70 years, mean 35.7 (SD 12.3) years. 
In our investigation of acetabular protrusion in MFS (paper III), the control cases were also 
chosen from the radiological archive (PACS) of the Department of radiology, Oslo university 
hospital, based on the following criteria: sex- and age-matched asymptomatic persons with 
respect to the hips and without any known connective tissue disorder, examined by CT of the 
abdominal and/or pelvic area due to symptoms from the abdominal area or with suspected 
vessel disease in the pelvic or abdominal region. Patients with liver or kidney transplants were 
excluded. The controls included 107 subjects, 68 women aged 19-69 years, mean 40.9 (SD 
13.7) years, and 39 men aged 19-64 years, mean 35.8 (SD 12.1) years.
6.2  Radiological examinations 
MRI of the thoracic aorta, the pulmonary artery, and the lumbosacral column was performed 
in one session unless contraindicated, when CT examinations were obtained instead. 
CT was used for tomographic imaging of the thoracic cage and the hip joints, and for 
projection imaging of the vertebral column (scout view). 
MRI of the thoracic aorta and the pulmonary artery was performed using a 1.5 T unit (Signa 
LX, GE Healthcare, Milwaukee, Wisconsin) in axial and oblique sagittal planes using a 
standard ECG-gated T1-weighted SE sequence without intravenous contrast medium
injection. Repetition time equalled the R–R interval, echo time was minimum 9.32 ms to 
maximum 39.976 ms, slice thickness was 7 mm in the axial plane, and 4 mm in the oblique 
sagittal plane. 
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CT of the thoracic aorta and the pulmonary artery was obtained on a ProSpeed SX scanner 
(GE Healthcare, Milwaukee, Wisconsin) with 5 mm slice thickness in patients in whom MRI 
was contraindicated. 
HRCT of the lungs was performed on a ProSpeed SX scanner (GE Healthcare, Milwaukee, 
Wisconsin) with 1 mm slice thickness and 10 mm distance between slices.
MR imaging of the lumbosacral spine in the study group was performed using a 1.5 T unit 
(Signa LX, GE Healthcare, Milwaukee, Wisconsin). T1-weighted (TR/TE = 375/9 ms) and 
T2-weighted (TR/TE = 3500/120 ms) turbo spin-echo sequences were obtained in the sagittal 
plane with 4 mm section thickness. The T2-weighted sequence was repeated in the coronal 
plane and in 5 angulated axial planes parallel to the 5 lumbar intervertebral disks. 
MR imaging of the lumbosacral spine in the control patients was performed with a 1.5 T unit 
(Signa, GE Healthcare, Milwaukee, Wisconsin) with sagittal and coronal T1-weighted fast 
spin-echo sequences (TR/TE = 500/9–13 ms) and sagittal and coronal short-inversion-time 
inversion recovery sequences (TR/TI/TE = 4300/150/34 ms). Section thickness and interslice 
gap were 4 and 0.5 mm for sagittal images and 7 and 1 mm for coronal images, respectively.
CT imaging of the hips in the study patients was performed by a ProSpeed SX scanner (GE 
Healthcare, Milwaukee, Wisconsin) with 3 mm slice thickness.
CT imaging of the hips in the control patients was performed on different scanners with slice 
thickness 3 mm or less.
6.3  Statistical approach 
All statistical analyses were performed by SPSS versions 13-18 (SPSS, Chicago, Il). 
Significance level was set to 5%. Continuous data were described as mean and standard 
deviation or median and range for normally distributed or skewed data, respectively. 
Categorical data were described as frequency and percentage.
Univariate statistical analyses on differences between groups were analyzed with independent 
sample t-test or chi-square, as appropriate, and correlation assessed with Pearson correlation 
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coefficient. Skewed data were analyzed with a non-parametric Kruskal-Wallis test. For 
continuous data, difference in mean between the study groups was analyzed with one-way 
ANOVA, and for multiple comparisons Tukey or Bonferroni post hoc test was done.
Pearson’s chi-square test was used for categorical data. Odds ratios were calculated for nerve 
root sleeve herniations. Multivariate analysis on factors influencing pulmonary artery 
diameter was done with a multiple linear model. Statistical analysis of dural sac diameter 
between the groups was adjusted for sex and age using a general linear model.
7. Summary of papers 
7.1  Paper I. Prevalence data on all Ghent features in a cross-sectional study 
of 87 adults with proven MFS. 
In order to investigate the phenotype, i.e. to explore the prevalence of each “major criterion” 
and “organ involvement” in an adult cohort with proven Marfan syndrome, we investigated 
105 adults with suspected MFS for all the features of the Ghent 1 criteria. Eighty seven (83%) 
fulfilled the different features through 56 different combinations of the major criteria and 
organ involvement.
Using the full version of the Ghent 1
criteria on 105 individuals refuted 
the MFS diagnosis in 13 out of 90 
patients who had been diagnosed 
earlier, and verified the diagnosis in 
10 of 15 persons with suspected 
MFS. Figure 4 gives an overview of 
the diagnostic results.
Figure 4. Diagnostic results for entire study group (n=105). Reproduced with permission from 
Svend Rand-Hendriksen (2).
The major dural criterion (DE) was fulfilled in 91% of the Ghent positive cohort, a major 
genetic criterion (positive family history and/or FBN1 mutation) was found in 89%, a major 
ocular criterion in 62%, and a major cardiovascular criterion in 53% of the MFS patients. The 
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major skeletal criterion was fulfilled in 38% of the Ghent positives. As much as 16% (14 
persons) of the Ghent positive cohort were dependent of DE to fulfill the diagnosis of MFS.
In spite of the great diversity of combinations to fulfill the diagnosis according to the Ghent 
nosology, a combination of the dural major criterion and the presence of genetic major criteria 
could identify 69 (79%) out of 87 affected individuals with MFS in our cohort. This indicates 
an early investigation of those systems when suspicion of MFS has been raised in adults.
7.2  Paper II. Dural ectasia in Marfan syndrome. A case control study. 
In order to investigate the prevalence of dural ectasia in a cohort of patients fulfilling the 
Ghent criteria for MFS, and to find the best criteria for assessment of dural ectasia, we studied 
the lumbosacral spine of 105 adults suspected of having MFS with MR imaging at 1.5 T 
(unless contraindicated, when CT was obtained instead). One-hundred and one sex and age-
matched persons screened for malignancy by MR imaging constituted the control group.
Dural ectasia (DE) is one of the major criteria of MFS in the Ghent 1 nosology and has been 
defined as "enlargement of the neural canal anywhere along the spinal column, but nearly 
always in the lower lumbar and sacral regions; thinning of the cortex of the pedicles and 
laminae of the vertebrae; widening of the neural foramina; or an anterior meningocele”. A
number of articles about MFS have presented methods on how to assess DE by using 
conventional x-ray films, CT, and MR imaging, but no gold standard for the diagnosis of DE 
has emerged.
We measured lumbosacral anteroposterior vertebral body diameters (VBD) and dural sac 
diameters (DSD). Dural sac ratios (DSR = DSD/VBD) at levels L3 through S1 were 
calculated. Anterior meningoceles, herniations of nerve root sleeves, and scalloping were 
characterized.
Three patient groups were identified: 1) fulfilling Ghent criteria independent of DE (n = 73), 
2) fulfilling Ghent criteria dependent on DE (n = 14), and 3) suspected MFS, not fulfilling 
Ghent criteria (n = 18). The control and study populations were compared in aggregate, and 
consensus readings in addition to interobserver agreement were studied.
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We found that:
1) Anterior meningoceles were present in Ghent-positive patients only.
2) Herniations of the nerve root sleeves were frequently present in Ghent-positive patients, in 
73% of group 1 (MFS independent of DE), and in 71% of the patients in group 2 (MFS 
dependent on DE). Only one person (1%) of the controls had herniation of a nerve root 
sleeve. 
3) DSD sacrum > DSD L4 was found in 52% of group 1, and in 29% of group 2. Five 
percent of the controls had this finding. 
4) DSR S1 > 0.59 was present in 59% of group 1, and in 85% of group 2, while 7% of the 
controls had this feature.
On the basis of the ROC analysis, a cut-off value of 0.59 for DSR at level S1 was suggested, 
giving a sensitivity of 70.5% and a specificity of 92.7% as a marker for MFS. A total of 86% 
of our Ghent-positive patients independent of DE fulfilled the combined signs of DE 
described above. 
We concluded that the above mentioned features (1-4) for DE should be the basis for the 
diagnosis of DE. MR imaging of the spine is encouraged to identify DE and thus strengthen a 
potential diagnosis of MFS.
7.3  Paper III. CT of the hips in the investigation of protrusio acetabuli in 
Marfan syndrome. A case control study. 
In order to establish the prevalence of protrusio acetabuli (PA) in adult persons fulfilling the
Ghent 1 criteria for MFS, and to find the best criteria for the assessment of PA, we studied CT 
of the hips in 105 adults with suspected MFS, and 107 sex- and age-matched controls. 
Asymptomatic persons with respect to the hips, and without any known connective tissue 
disorder, examined by CT of the abdominal and/or pelvic area chosen from the radiological 
archive in our department, constituted the control group. Eighty-seven of the 105 persons 
suspected of having MFS fulfilled the Ghent 1 criteria (= Ghent positive).
PA is an inward protrusion of the acetabulum as a rounded mass into the pelvis, and varies 
from a few millimeters to five centimeters, and is seen in different disorders including 
primary idiopathic cases or secondary to neoplastic, infectious, metabolic, inflammatory, 
traumatic, congenital and genetic disorders.
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PA is one of the eight manifestations that may contribute to the major skeletal criterion for 
Marfan syndrome (MFS) according to the Ghent 1 nosology, and is included as one of the 
features of the “systemic score” in the newly revised Ghent 2 criteria. Diagnosing PA has 
been a point of discussion since the accuracy of measurements on conventional pelvic 
radiographs is uncertain and may vary with pelvic tilt. Few authors have assessed the different 
radiological methods in a validated way, and the definition of PA has varied depending on the 
radiological method.
A qualitative assessment of PA was performed. A new method for estimating the degree of 
PA was introduced with measurement of the parameter CWD (circle-wall distance), where a 
circle with 10 cm radius was fitted to the inner pelvic wall at the level of the acetabulum. 
PA was diagnosed qualitatively in 74.7% of Ghent positive persons, in 27.8% of Ghent 
negative persons (the 18 persons suspected of MFS without fulfilling the Ghent 1 criteria),
and in 3.7% of the controls. PA was bilateral in 81.5% of Ghent positive persons, and in 50% 
of controls. CWD was significantly different between the three groups (p<0.001). ROC 
analysis of CWD vs. qualitative diagnosis of PA showed an area under the curve of 0.99 (95% 
CI 0.98–1.0); a CWD cut-off value of 1.25 mm resulted in a sensitivity and specificity for PA 
of 95.5% and 97.6%, respectively. Interobserver agreement for assessing PA qualitatively was 
KLJKZLWKDNDSSDYDOXHțRI&,–0.95) for the right hip and 0.92 (CI 0.81–
1.0) for the left hip. The circle method had an interclass correlation coefficient (ICC) of 0.91 
(95% CI 0.89–0.95) and 0.89 (95% CI 0.81–0.93) on the right and left side, respectively.
We concluded that PA was found significantly more often in MFS persons than in controls. 
Both our CWD and qualitative method was found to be robust and highly reproducible, giving 
a direct assessment of pelvic protrusion irrespective of pelvic shape or tilt.
7.4  Paper IV. The pulmonary artery in Marfan syndrome patients. A cross-
sectional study. 
In order to establish the prevalence of pulmonary artery dilatation in Marfan syndrome (MFS) 
by radiological methods, to correlate diameter of the vessel with aortic disease, and explore 
predictors of pulmonary artery dilatation in MFS, we performed MR or CT imaging of the 
pulmonary artery and aorta in 87 patients with proven MFS. According to the Ghent 1 
nosology “dilatation of the main pulmonary artery, in the absence of valvular or peripheral 
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pulmonary stenosis or any other obvious cause, below the age of 40 years”, is considered a 
minor cardiovascular criterion of MFS. 
Axial diameters of the pulmonary artery root and trunk were measured perpendicular to the 
long axis of the vessel on axial images. Aortic root diameters were measured on oblique 
sagittal images perpendicular to the long axis of the vessel. Measurements were compared to 
normal values based on MR and CT in the literature.
MR and CT measurements of the pulmonary artery showed mean (SD) diameters of the 
pulmonary artery root and trunk of 35.0 (4.6) mm and 29.8 (3.8) mm, respectively. According 
to Ghent 1 criteria for pulmonary artery dilatation, which are based on nomograms of the 
aortic root, 7 out of 39 patients (17.9%) under 40 years of age had dilated pulmonary artery 
root, while none had dilatation of the pulmonary artery trunk. Compared to published normal 
values for adult pulmonary artery trunk diameters, 47 (54%) of the 87 patients had dilated 
pulmonary artery trunk, i.e.  mm.
Thirty (34.5 %) of the 87 Ghent positive patients had previous surgery on the ascending aorta. 
The remaining 57 MFS patients without previous aortic surgery had echocardiographic 
measurements indicating that 16 had dilated aortic root according to the Ghent 1 criteria 
(nomograms by Roman et al.). However, when the aortic root diameters were reassessed with 
MR or CT, 40 of these 57 patients had dilated aortic roots according to the same criteria.
Thus, based on MR or CT a total of 70 (80.5%) patients fulfilled the major cardiovascular 
criterion for MFS, i.e. had an operated or dilated ascending aorta.
Pulmonary artery root and trunk diameters were significantly larger in patients with previous 
surgery on the ascending aorta compared to those without such surgery (p=0.041 and 
p=0.027, respectively). Pulmonary artery trunk diameters were significantly larger in patients 
with ascending aortic disease (dilatation or previous surgery) than in those without (p=0.018), 
but the pulmonary artery root diameters were not significantly larger in this patient group 
(p=0.104). A multivariate analysis suggested that previous surgery on the ascending aorta was 
a significant predictor of pulmonary artery trunk dilatation, but not of pulmonary artery root 
dilatation. 
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Seven (14.9%) of the 47 patients with dilated pulmonary artery trunk diameter (PP) had 
normal diameter of the aortic root, while 20 (42.6%) had a dilated native aortic root, and 20 
(42.6%) had previous surgery on the ascending aorta.
We concluded that pulmonary artery dilatation is a common finding in MFS (54%), and 
should be assessed using cut-off values based on pulmonary artery diameter measurements in 
the normal population. MR or CT imaging seems to provide more reliable results for 
pulmonary artery dimensions than echocardiography. Severe disease of the ascending aorta is 
a significant predictor of pulmonary artery trunk dilatation in MFS patients, but such 
dilatation may occur even in the absence of visible aortic disease.
8. Discussion 
8.1  Study and control populations 
The Norwegian Marfan study intended to be a cross-sectional study of the adult Norwegian 
MFS population. All criteria for the syndrome were examined according to the Ghent 1 
criteria. One hundred and five persons were included, and 87 of these fulfilled the Ghent 1 
criteria for MFS. Through the invitation letters sent to patients with proposed MFS, and 
through the advertisement in the Journal of the Norwegian association of MFS and MFS-like 
disorders, we believe that the majority of the genuine patient group was informed. Despite the 
fact that MFS affects men and women equally often, there was a skewed gender 
representation in our study, 64% of the participants being women. This might be accidental, 
but could also reflect a gender difference in the willingness to participate in studies. In 
addition, the men as a group were younger than the women, and these facts together may 
constitute a bias selection.
Control patients were included in our assessment of dural ectasia and acetabular protrusion in 
MFS. The prevalence of dural ectasia in the general population was not known, and previous
case control studies addressing this topic were few and had control groups that (with one 
exception) tended to be small. The control groups had furthermore not been sex- or age-
matched, and they included patients with low back symptoms (40;45;47-49). Our control 
group for DE included 101 sex- and age-matched controls without low back symptoms,
giving us reason to assume that our findings in that group would be representative for a 
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normal population. Our results indicate that DE is a common finding in MFS, but present in 
only a few percent of healthy persons without back pain.
Our main reason for including controls in our examination of acetabular protrusion was lack 
of knowledge concerning the prevalence and degree of protrusion in the normal population 
when assessed with CT. No previous studies on this topic were found. To avoid radiation 
exposure to healthy persons by CT, no healthy volunteers were included; all 107 sex- and age-
matched controls were chosen from the radiological archive of our hospital.
8.2  Radiological methods 
In our investigation of the study population we intended to use radiological methods 
described by the Ghent 1 article published in 1996 (1). However, we did a pilot study of 23
patients with suspected MFS, 18 fulfilled the Ghent 1 criteria for MFS, and based on this pilot 
study it was decided that some radiological examinations could be exchanged with more 
modern methods. For examination of the hips for protrusio acetabuli radiography was 
exchanged with CT because the latter method gives much more detailed information of the 
acetabular shape than does conventional radiography. MR imaging of the vertebral column in 
the investigation of DE was chosen instead of CT or radiography because this method depicts
soft tissue as the dural sac, better than does CT or radiography, and in addition it does not 
include ionizing radiation. CT of the thoracic cage depicts blebs in the lungs far better than 
radiography. To optimize examination of the ascending aorta, MR imaging was chosen in 
addition to echocardiography.
The examinations in our study were performed in the period of 2003-2005, and since then MR 
and CT techniques have improved substantially. To reduce possible side-effects to a 
minimum, contrast-enhanced imaging was not included, resulting in less than optimum 
imaging of the aorta and pulmonary artery. Today, non-enhanced 3D MRI using a balanced 
gradient echo sequence with ECG and respiratory gating would have been used for imaging of 
the great thoracic vessels, but although our ECG-triggered 2D TSE sequences are far from 
today’s state of the art, they are still adequate for diameter measurements. 
32 
 
8.3  Prevalence data on all Ghent features (paper I) 
In this cross-sectional study of 105 adults suspected of having MFS, all patients were 
examined by the same group of investigators with standardized and complete assessment of 
all features in the Ghent 1 criteria. Eighty-seven patients fulfilled the criteria in as much as 56
different combinations of criteria and involvement. That confirms the need for the complete 
Ghent criteria to be identified in studying MFS, although the majority of them could have
been identified by combined assessment of dura and the family history, supplemented with 
DNA analysis in family-negative cases.
Dural ectasia was found in 91% of the MFS patients, and DE was the sign most prevalent of 
all the Ghent criteria, followed by the major genetic criterion (89%), and ectopic lenses
(62%). We based our diagnostic criteria for DE on a combination of findings from our own 
case control study of DE and proposed signs of DE from the literature. In addition to 
qualitative signs for DE and DSD sacrum > DSD L4, cut-off values of DSR at level L5 and 
S1 according to Oosterhof et al. (40) were used as diagnostic criteria for DE. However, 
Oosterhof et al. proposed a combination of elevated DSR at level L3 and S1 as a specific 
indicator to identify MFS (40). In our study, DSR at level L3 had no discriminating value for 
the presence of MFS because we found no significant differences between Ghent-positive 
patients independent of DE and the controls.
The prevalence of DE in our study was among the highest found in the literature, but it was 
comparable to studies by Oosterhof et al. (95%) and Fattori et al. (92%) (40;49). Pyeritz et al.
found a lower prevalence of DE (63%) in 1988 (46), and Radonic et al. found DE in 76% of 
their patients in an article published in 2011 (22). As much as 16% (14 persons) of the Ghent 
positive patients were dependent of DE to fulfill the diagnosis of MFS. This underscores the 
importance of investigating this feature of MFS. In the Ghent 2 criteria DE is given less 
significance than in the Ghent 1 nosology. In a newly published study by Radonic et al. (22)
180 Ghent 1 positive patients were tested for the Ghent 2 nosology; three patients with dilated 
ascending aorta according to the new z-score system used by the Ghent 2 nosology, had their 
diagnosis of MFS rejected because of low systemic score according to Ghent 2. None of these 
three were found to have any other connective tissue diseases. These patients fulfilled Ghent 1 
based on two major criteria, dilatation of the aortic root and DE in addition to involvement of 
another system. Because of the reduced significance of DE in Ghent 2, the criteria for MFS 
were not fulfilled.
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Protrusio acetabuli (PA) is regularly found in MFS patients, and CT of the hips was chosen 
instead of conventional radiography, partly because previous studies had given varying results
dependent on method for assessment of PA by conventional radiography, and also because 
CT is a superior method to depict bony structures. We used an ellipse to assist us in the 
qualitative evaluation PA, and defined PA as present when the bottom of the acetabulum 
protruded into the ellipse. We found protrusio acetabuli in 52 (59.8%) of the 87 MFS patients.
Our evaluation of the radiological findings was later refined, leading to an even higher 
prevalence of PA in our MFS patients, 74.7% (paper III).
HRCT was chosen to study blebs in the lungs, a criterion of the Ghent 1 nosology. We found 
apical blebs in 16 out of 87 MFS patients. In a study by Wood et al. in 1984, only 5 out of 
hundred MFS patients had apical blebs based on conventional radiography examinations (64).
Our findings probably reflect the much higher sensitivity of HRCT compared with 
conventional radiography in detecting changes in the lung parenchyma. In addition to blebs in 
the lungs the HRCT study made it possible to depict pectus excavatum and carinatum. Pectus 
carinatum was found in 57 (65.5%) of our MFS patients. 
We assessed scoliosis based on scout views from the CT examinations performed. Additional 
conventional radiography in the erect position would have been a better method to study 
scoliosis, but emphasis was put on minimizing radiation to the patient. Scoliosis and/or 
spondylolisthesis were found in 26.4% of the MFS patients.
The ascending aorta was measured by echocardiography and MRI in our study, but in paper I
results were based on echocardiography only, in accordance with the Ghent 1 nosology 
(1;65). The prevalence of ascending aortic disease (major cardiovascular criterion) was 53%,
and that of mitral valve prolapse 14% in our study, and was among the lowest reported in
individuals fulfilling the Ghent 1 criteria. As most studies that were found in the literature
emerged from specialized 4th level cardiovascular centres serving individuals with severe 
aortic or cardiovascular disease, patient selection may explain the high prevalence of 
cardiovascular pathology in other reports. In the hindsight's light, another explanation of why 
the number of patients with affected ascending aorta was relatively low, could be that our 
echocardiographic measurements underestimated aortic diameters. There was a large
discrepancy between the echocardiographic and the MR/CT results on diameter of the 
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ascending aorta, where MR/CT gave a much higher prevalence of ascending aorta disease
(paper IV).
According to the Ghent 1 criteria none of our MFS patients had dilated pulmonary artery. In 
the discussion of paper I we wrote: “Using Nollen's upper limit of normality for the 
pulmonary artery trunk, 34.8 mm, 13 out of 87 persons fulfilling Ghent had enlarged 
pulmonary trunk (median diameter 30 mm; range 23–38 mm)”. The problem with this 
statement is that the wrong cut-off value, the cut-off value for the pulmonary artery root
instead of the trunk, was used. The cut-off value proposed by Nollen et al. for the trunk was 
28 mm, which would have given a much higher prevalence of dilatation of the pulmonary 
artery (66). Also De Backer et al. used Nollen´s cut-off values wrong in their article on minor 
cardiovascular signs in MFS (67). So there has been a general confusion in the literature on 
the pulmonary artery in MFS patients. MRI with modern sequences should be used for 
assessment of the pulmonary artery trunk diameter, and pulmonary artery cut-off values must 
be used instead of aortic cut-off values.
8.4  Dural ectasia (paper II)  
Dural ectasia is found in a high percentage of MFS patients, and was according to the Ghent 1 
nosology a major criterion for this disease. A proportion of the MFS patients are dependent of 
DE to fulfill the diagnostic criteria for MFS. In our study 14 (16%) out of the 87 MSF patients 
were dependent on the finding of DE to get the diagnosis. This was in line with the result in a 
study by Sznajder et al., 2010 (42) where 10% of their MFS patients were dependent of DE to 
fulfill the criteria for MFS. This strengthens the proposal that the lumbosacral spine should be 
imaged when MFS is suspected.
We divided the study patients in three groups: (1) fulfilling Ghent 1 independent of DE, (2) 
fulfilling Ghent 1 dependent of DE, and (3) not fulfilling Ghent 1. By adding a large control 
group, the prevalence of DE in the healthy population could also be assessed.
Assessment of DE in our study included qualitative and quantitative signs. Qualitative signs 
were anterior meningoceles (i.e. spinal fluid collection covered by dura inside the pelvic 
cavity) or herniation of dura along the nerve root sleeves. Quantitative signs included DSD 
sacrum > DSD L4 suggested by Ahn et al. (51), and cut-off values for DSR at level L5 and S1
suggested by Oosterhof et al. (40). Oosterhof et al. found that a combination of DSR at level 
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L3 and DSR at level S1 had a high diagnostic sensitivity and specificity for MFS (40). As a 
marker of MFS, DSR at level S1 had the highest sensitivity and specificity in our study. DSR
at level L5 gave the second best results. No significant differences at level L3 between DSR
of Ghent positive patients independent of dura and controls were found. By including 
qualitative findings, and replacing the cut-off values for DSR proposed by Oosterhof et al. at 
level L5 and S1 by a cut-off value at level S1 of 0.59, the prevalence of DE was found to be 
86% in group 1 (MFS patients not dependent on DE for their diagnosis), and 9% in the 
controls. Söylen et al. found in their case control study of MFS patients that according to the 
method of Oosterhof et al. 88% of MFS patients and 47% of controls had dural ectasia
(40;68).
Some recent reports about DE in MFS have postulated that quantitative signs of DE have 
major advantages over qualitative assessments because cut-off values can be used more 
uniformly than qualitative signs (40;48). We found qualitative signs as nerve root sleeve 
herniation and anterior meningocele very useful because they are highly specific for DE. Ten
of our patients would not have been assigned the major criterion DE if nerve root sleeve 
herniation had not been a sign of that feature. The presence of nerve root sleeve herniation at 
at least one vertebral level had a sensitivity of 72.6% (95% confidence interval [CI], 67.6%–
77.6%) and a specificity of 99.0% (95% CI, 95.4%–99.8%) in diagnosing MFS. 
Although the dural sac is a soft-tissue structure, DE has been defined to include bony changes 
of the spine, such as thinning of the cortex of the posterior vertebral elements, widening of the 
neural foramina, and vertebral scalloping in addition to the presence of a patulous dural sac 
and anterior meningoceles (1;69). MR imaging, like CT and conventional radiographs,
identifies the secondary osseous changes associated with DE, but MR imaging also allows the 
direct visualization of the soft tissues of the entire spine. In the ongoing discussion on which 
methods are necessary to depict DE, Sznajder et al. have recently suggested that conventional
radiography should be used as first line screening for suspected MFS patients, and that CT or 
MRI should be reserved for unresolved cases (42). Conventional radiography was found to 
have a low sensitivity (35.3%), but very high specificity (100%), indicating that the majority 
of DE cases would remain undetected using radiography alone (42).
The Ghent 2 nosology regards DE as a sensitive but unspecific sign of MFS (8). It is argued
that no preferred methods (CT or MRI) or uniformly accepted cut-off values for DE have 
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emerged from the literature. In our study using MR imaging, we compared MFS patients 
independent of DE to controls, and found that the presence of nerve root sleeve herniation at 
one or more levels had high specificity for MFS compared to controls. In line with this, DE 
was not identified as an incidental finding in a study concerning MR imaging of the lumbar 
spine in persons without back pain (70). On the basis of our ROC analysis, a cut-off value of 
0.59 for dural sac ratio at level S1 was suggested, giving a sensitivity of 70.5% and a 
specificity of 92.7% as a marker for MFS.
We recognize that DE is found in other connective tissue diseases, such as neurofibromatosis 
1, Ehlers-Danlos syndrome and Loeys-Dietz syndrome, and it may be argued that DE is a sign 
of inherited connective tissue disorders. Based on our study we believe that DE is sensitive 
and specific for connective tissue diseases, including MFS. It is a well documented sign for 
these diseases, and its detection should be given preference in the diagnostic process of MFS.
8.5  Protrusio acetabuli (paper III) 
Protrusio acetabuli (PA) is regularly described in MFS patients, but we found only one study 
based on MR examinations (62) in the literature, and none based on CT. Radiography of the 
hips on this indication is described in many papers (55;58-60;71). The reported prevalence of 
PA in MFS based on conventional radiography has varied in different studies (56). Sponseller
et al. studied PA in children and adults with MFS and found different percentages of PA 
depending on the method of assessment; Steel´s method (59) gave 27% of the patients the 
diagnosis of PA, while the method by Armbuster (57) gave 16% (58).
A newly published study by Richards et al. concludes that as pelvic tilt increases, classic 
radiographic measurements of PA become unreliable (61). The authors found too much 
variation in the results to recommend any standard radiographic test. They claim that despite a 
variety of radiological measurements, few authors have assessed the different methods of 
radiological analysis in a validated way.
In our case control study CT was chosen due to its direct visualization of the acetabular shape 
and its superior depiction of cortical bone. Qualitative assessment of PA in our study was 
defined as any degree of intrapelvic protrusion of the medial pelvic wall at the level of the 
acetabulum. Using this criterion, we found a very high percentage of PA in our MFS persons 
(74.7%) as compared to the controls (3.7%). The finding of PA in 27.8% of the persons 
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suspected of having MFS but not fulfilling the Ghent criteria probably reflects that several of 
these persons had other connective tissue diseases that might predispose for PA. For 
quantification of PA we introduced a circle with 10 cm radius and measurement of the circle-
wall distance (CWD). The circle was fitted to the inner pelvic wall at the level of the 
acetabulum, and CWD was measured as the distance from the circle to the most medial point 
of the inner acetabular wall. Measurement of CWD was easily performed with a high 
interobserver reproducibility. ROC analysis of CWD vs. qualitative diagnosis of PA showed 
an area under the curve of 0.99 (95% CI 0.98–1.0); a CWD cut-off value of 1.25 mm resulted 
in a sensitivity and specificity for PA of 95.5% and 97.6%, respectively. ROC analysis of 
CWD in differentiating MFS patients from controls showed a sensitivity and specificity in 
diagnosing MFS of 68.8% and 97.2%, respectively, when using a CWD cut-off value of 1.25 
mm. Measurement of CWD appears to be a useful method in estimating the degree of PA, but
the simplest way to determine whether PA is present is to evaluate the shape of the inner 
acetabular wall at CT (or MRI); any inward protrusion should be termed PA.
In our assessment of PA, we also evaluated an MRI-based method published by Chen et al.
(62). Measurement of acetabular protrusion according to Chen et al. was possible in 68.9% of 
all study persons and controls. Chen’s method requires that the ischial spine is depicted in the 
same axial image as the medial most point of the acetabular fossa, and this was often not the 
case. When the method could be used, it had a high interobserver reproducibility, but a low 
accuracy in detecting PA. No statistically significant differences were found between 
controls, Ghent positive patients, and Ghent negative persons suspected of having MFS.
Our study indicates that CT is a reliable method that should replace conventional radiography
in the diagnosis of PA. CT of the hips may be performed with low radiation dosage, but if 
radiation dosage is a concern (young patients, repeated examinations), MRI may be 
performed instead, most likely with the same accuracy as CT.
8.6  Pulmonary artery (paper IV) 
Our study showed that when compared to normal values in healthy adult persons (72), more 
than half (54%) of our adult patients with proven MFS had dilatation of the pulmonary artery 
trunk, some (approx. 15%) even in the absence of dilatation of the aortic root or ascending 
aorta.
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The Ghent 1 criteria of 1996 (1;72) included dilatation of the pulmonary artery as a sign 
(minor vascular criterion) of MFS, but in the revised criteria (Ghent 2) published in 2010 (8),
this criterion was omitted. Reasons given were that pulmonary artery dilatation is not specific
to the diagnosis of MFS, that complications of pulmonary artery disease are rarely seen, and 
that further research is needed regarding thresholds and the diagnostic utility of this finding
(8). The uncertainty regarding threshold values for pulmonary artery dilatation is partly 
caused by the vagueness of the Ghent 1 criteria with respect to the pulmonary artery. The 
authors state that “until normal values for pulmonary artery diameter are available, dilatation 
can be detected provisionally by echocardiography, CT or MRI using nomograms for the 
aorta” (1). Furthermore, the Ghent 1 criteria do not specify which part of the pulmonary artery 
should be measured, the root or the trunk. In search for literature on the pulmonary artery 
diameter we found that most papers addressing upper normal values for the pulmonary artery 
have considered the pulmonary artery trunk only, and among those performed with axial 
imaging (66;72-75), only three have included an adequate number of subjects (72;74;75). The 
126 subjects studied by Bozlar et al. (72) were imaged with nearly the same slice thickness as 
our MFS patients, and the age distribution was furthermore similar, 30.6 ± 7.9 years and 35.1 
± 11 years, respectively. Pulmonary hypertension and thoracic pathology had been excluded. 
We therefore consider this group of healthy adults as an adequate control group for our study.
In our study “Prevalence data on all Ghent features in a cross-sectional study of 87 adults with 
proven Marfan syndrome” (paper I) we found no MFS patients with dilated pulmonary artery 
based on the Ghent 1 criteria. The large discrepancy between the findings of pulmonary artery 
dilatation using nomograms for the aorta as recommended by Ghent 1 (1) and when using cut-
off values based on 2 SD above the mean value in healthy volunteers, suggests that 
nomograms for the aorta are not suited for assessment of pulmonary artery dilatation.
Our preliminary measurements of native (not operated) aortic root diameters were performed 
with echocardiography and resulted in 16 out of 57 MFS patients having dilated aortic root. 
When remeasured with MR or CT, the number increased to 40 of 57. All aortic diameter 
measurements (echocardiography, MR, CT) were plotted into a nomogram based on 
echocardiographic measurements and included in the Ghent 1 criteria (1;65). The unusually 
low prevalence of aortic root dilatation when measured with transthoracic echocardiography, 
suggests that aortic root diameters were underestimated using this method. Echocardiographic 
measurement of the aortic root is commonly performed using a parasternal long-axis view of 
39 
 
the aortic root and measuring from “leading edge to leading edge”, i.e. including the anterior 
wall but not the posterior wall in the diameter measurement. The acoustic window is 
restricted, and the maximum diameter of the vessel may not be included in the scan plane. 
Aortic aneurysms are defined by their maximum outer diameter, and assessment of aortic 
diameters with MRI or CT therefore usually includes the vessel wall on both sides of the 
lumen. In addition, axial MRI and CT may overestimate vessel diameter due to obliquity of 
the vessel with respect to the axial plane. Such overestimation will increase with increasing 
slice thickness due to partial volume effects. A source of error is also the pulsatile variation in 
aortic diameter from diastole to systole. With the multislice ECG-triggered MR technique 
used in our study, the different slices will be imaged at different time points throughout the 
cardiac cycle. The above mentioned factors may all have contributed to the discrepancies 
between echocardiographic and MRI/CT measurements. The major differences in imaging 
techniques also underscores the importance of using nomograms based on the same imaging 
modality as the one used for measurements. 
The Ghent 2 criteria suggest that a recent ECG-gated 64 channel MDCT study by Lin et al. 
(34) should be used as reference material for CT examinations of the aorta. Here reference 
values in adults for end-diastolic true short axis luminal diameters and areas of the aortic root 
are presented. Lin et al. have also published reference values for the pulmonary artery using 
the same MDCT technique (76). Due to the oval shape of the pulmonary artery in true short 
axis view, averaged pulmonary artery diameters are presented as reference values. 
Unfortunately, these reference materials could not be used in our study due to the differences 
in examination techniques.
Although a large majority of the patients with dilated pulmonary artery trunk also had aortic 
disease (40 out of 47 or 85.1%), a few of these patients (7 out of 47, 14.9%) had no sign of 
ascending aortic disease, suggesting that pulmonary artery dilatation may be an early marker 
of vascular disease in MFS patients.
The clinical implications of our findings are important. Pulmonary artery trunk dilatation is 
common in MFS patients, and does not by itself imply pulmonary hypertension. Dilatation of 
this vessel in an MFS patient may suggest MFS-related vascular affection even in the absence 
of visible ascending aortic disease.
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9. Conclusions 
The general aim of this thesis was to explore the prevalence of different manifestations of 
Marfan syndrome by using radiological methods, and to evaluate different imaging methods 
in each organ system examined by radiological methods. 
x We found that in spite of a great diversity of combinations in fulfilling the diagnosis 
according to the Ghent nosology, a combination of the dural major criterion and the 
presence of genetic major criteria could identify a high percentage (79%) of all affected 
individuals with MFS in our study population. This indicates an early investigation of 
dura and genetic major criteria when suspicion of MFS has been raised in adults.
x MR imaging of the lumbosacral spine is encouraged to identify DE and thus strengthen a 
potential diagnosis of MFS. DE was found in a high percentage of our MFS patients (89% 
of patients diagnosed as MFS without use of the criterion DE), and has a high specificity 
for MFS. As much as 16% of the Ghent-positive patients were dependent of DE to fulfill 
the diagnosis of MFS.
We suggest that the diagnosis of dural ectasia should be based on the presence of at least 
one of the following criteria: 1) an anterior meningocele or nerve root sleeve herniation, 2) 
DSD at level S1 or below larger than DSD at level L4, 3) DSR at level S1 > 0.59.
x CT should be preferred to radiography in the diagnosis of PA. If radiation is a concern, 
MRI may be used instead of CT. PA was found in more than two thirds of patients with 
MFS. It has a low sensitivity, but a high specificity for the diagnosis of MFS. Our 
measurement method CWD for assessment of degree of PA, was found to be robust and 
highly reproducible, giving a direct measurement of pelvic protrusion irrespective of 
pelvic shape. 
x Pulmonary artery dilatation is a common finding in MFS (54%), and should be assessed 
using cut-off values based on pulmonary artery diameter measurements in the normal 
population, and not on nomograms intended for the aorta. MR or CT imaging seems to 
provide more reliable results for pulmonary artery dimensions than echocardiography. 
Severe disease of the ascending aorta is a significant predictor of pulmonary artery trunk 
dilatation in MFS patients, but such dilatation may occur even in the absence of visible 
aortic disease.
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10. Errata 
x Paper I, “Prevalence data on all Ghent features in a cross-sectional study of 87 adults 
with proven Marfan syndrome”, Discussion, page 1227, second column: It is stated that 
“Nollen’s upper limit of normality for the pulmonary trunk” was 34.8 mm. This is 
incorrect; it should have been 28.0 mm. 
x Paper II, “Dural Ectasia in Marfan Syndrome: A Case Control Study”. Two errors occur: 
1) “Study Population”, page 1535, first column: the mean (SD) ages are incorrect, it
should have been: mean (SD) age in men 35.1 (11.1) years, and in female 42.1 (13.5) 
years. 2) “MR Imaging or CT of patients in the Study Population”, page 1535, first 
column: incorrect name of MR unit, it should have been: “Signa LX, GE Healthcare, 
Milwaukee, Wisconsin”.
x Paper III, “CT of the hips in the investigation of protrusio acetabuli in Marfan syndrome. 
A case control study”. Discussion, page 1490, first column: It is stated that “Steel et al. 
studied PA in children and adults with MFS and found different percentages of PA 
depending on the method of assessment; Steel´s method [12] gave 27% of the patients the 
diagnosis of PA while the Armbuster method [13] gave 16%”. It should have been 
“Sponseller et al. studied PA in children....”
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Abstract
Objectives To establish the prevalence of protrusio acetabuli
(PA) in adults fulfilling the Ghent criteria for Marfan
syndrome (MFS), and in a normal adult population.
Methods 105 adults with probable MFS and 107 controls
were included. CT of the hips was obtained. A qualitative
assessment of PA was performed. A new method for
estimating the degree of PA was introduced with measure-
ment of the parameter CWD (circle-wall distance). Results
were compared to an alternative method based on MRI [1].
Results 87 of the study group fulfilled the Ghent criteria of
MFS (Ghent positives), and 18 did not (Ghent negatives).
PA was diagnosed qualitatively in 74.7% of Ghent positive
persons, in 27.8% of Ghent negative persons, and in 3.7%
of the controls. CWD was significantly different between
the three groups (p<0.001). A slight but significant gender
difference was found in Ghent positive persons only. The
alternative method did not differentiate between the groups
with respect to PA, but showed a significant difference
between genders.
Conclusions PAwas found significantly more often in MFS
persons than in controls. Our method was found to be robust
and highly reproducible, giving a direct measurement of
pelvic protrusion irrespective of pelvic shape.
Keywords Marfan Syndrome . Computed tomography
(CT) . Hip joint . Pelvic bones . Connective tissue diseases
Introduction
Protrusio acetabuli (PA) is an inward protrusion of the
acetabulum as a rounded mass into the pelvis [2]. Pelvic
intrusion and acetabular protrusion seem to be used
synonymously. The degree of protrusion varies from a
few millimetres to five centimetres [2]. PA is seen in
different disorders including primary idiopathic cases and
secondary to neoplastic, infectious, metabolic, inflammato-
ry, traumatic, congenital and genetic disorders [3].
PA is one of the eight manifestations that may contribute
to the major skeletal criterion for Marfan syndrome (MFS)
according to the Ghent nosology [4] (Table 1), and is
included as one of the features of the “systemic score” in
the newly revised Ghent criteria [5].
A number of radiological features of PA have been
suggested, but no gold standard has emerged [6–8]. A
newly published study concludes that as pelvic tilt
increases, classic radiographic measurements of PA
become unreliable, and that computed tomography or
magnetic resonance (MR) imaging probably will be more
reliable [9].
In this case control study the aims were to establish the
prevalence of PA in adult persons fulfilling the Ghent criteria
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Table 1 Diagnostic Criteria for Marfan syndrome (MFS) according to the Ghent nosology
System Major criteria Criterion for involvement
Skeletal Requires four of the eight manifestations
listed below
Requires two of the eight manifestations in the left
column or one manifestation plus two minor criteria
Manifestations: Minor criteria
• Pectus carinatum • Pectus excavatum of moderate severity
• Pectus excavatum requiring surgery • Joint hypermobility (Beighton score≥4)
• Reduced upper to lower segment ratio<0.85
or Arm span to height ratio greater than 1.05
• Highly arched palate with crowding of teeth
• Wrist and thumb signs • Facial appearance (dolicocephaly, malar hypoplasia,
enopthalmos, retrognathia, down-slanting
palpebral fissures)
• Scoliosis of>20° or spondylolisthesis
• Reduced extension at the elbows (< 170°)
• Medial displacement of the medial
malleolus causing pes planus
• Protrusio acetabuli of any degree
Ocular Ectopia lentis Requires two of the following three minor criteria
Minor criteria
• Abnormally flat cornea (< 41,5 dioptres)
• Increased axial length of the ocular globe (>23,5 mm)
• Hypoplastic iris or ciliary body
Cardiovascular • Dilatation of the ascending aorta with or without
aortic regurgitation and involving at least the
sinuses of Valsalva
Requires the presence of at least one major criterion or
one minor criterion
• Dissection of the ascending aorta Minor criteria
• Mitral valve prolapse with or without mitral valve
regurgitation
• Dilatation of the main pulmonary artery in the absence
of valvular or peripheral pulmonic stenosis or any
other obvious cause below the age of 40 years
• Calcification of the mitral annulus before the age
of 40 years
• Dilatation or dissection of the descending thoracic
or abdominal aorta below the age of 50 years
Pulmonary None Requires at least one minor criterion
Minor criteria
• Spontaneous pneumothorax
• Apical blebs
Skin and Integument None Requires at least one minor criterion
Minor criteria
• Striae atrophicae (stretch marks) not associated with
marked weight changes, pregnancy or repetitive stress
• Recurrent or incisional herniae
Dura mater Major Criterion: None
• Lumbosacral dural ectasia
Genetic • Having a parent, child or sib who meets
these diagnostic criteria independently
None
• Presence of a mutation in FBN1 known
to cause the Marfan syndrome
• Presence of a FBN1 haplotype around FBN1, inherited
by descent, known to be associated with unequivocally
diagnosed Marfan syndrome in the family
Confirmation of the diagnosis requires the presence of at least two Major Criteria in two different organ systems and involvement of third organ
system. Family history / genetic is counted as an organ system
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for MFS, and to find the best criteria for the assessment of PA.
CTwas chosen due to its direct visualization of the acetabular
shape and its superior depiction of cortical bone.
Materials and methods
The study was approved by the Regional Medical Ethics
Committee.
For the purpose of informed consent only persons aged
above 18 years were included.
Study population
The participants were recruited either by letter sent to the
134 individuals above 18 years of age registered in a
National resource centre as having MFS; by advertisement
in the journal of the National Association of MFS, or
through invitations distributed in the Department of
Thoracic and Cardiovascular Surgery at our hospital to
patients suspected of having MFS. Age was the only
exclusion criterion.
Out of 109 individuals that gave informed consent for
participation, one died before the study started; one living
abroad was not able to attend, and two withdrew.
Consequently, the study population consisted of 105
persons, 67 women aged 20–69 years, mean 41.2 years
(SD 13.6), and 38 men aged 19–62 years, mean 35.1
(SD 11.3) years. Before inclusion, 90 had been given a
diagnosis of Marfan syndrome; 15 were suspected of
having the diagnosis. All participants were Caucasian.
All persons in the study group were assessed for all parts
of the Ghent criteria [4] by the same group of physicians.
The assessment included sequencing of the entire coding
region of the gene FBN1 and search for large deletions or
duplications [10, 11].
Control population
The control cases were chosen from the pool of patients
in the radiological archive (PACS) of the Department of
Radiology, based on the following criteria: Sex- and
age-matched asymptomatic persons with respect to
the hips and without any known connective tissue
disorder, examined by CT of the abdominal and /or
pelvic area due to symptoms from the abdominal area
or with suspected vessel disease in the pelvic or
abdominal region. Patients with liver or kidney trans-
plants were excluded. The controls included 107 sub-
jects, 68 women aged 19-69 years, mean 40.9 years
(SD 13.7), and 39 men aged 19-64 years, mean 35.8
(SD 12.1) years.
CT imaging
Axial CT images with 3 mm slice thickness were obtained
in the study population with a GE Prospeed SX CT system
(General Electric Medical Systems, Milwaukee, WI, USA)
and with different CT systems in the control population.
Image evaluation
The control and study populations were compared in
aggregate. Consensus readings of 75 CT examinations of
the study group and 77 of the control group were performed
by two radiologists (RL and EK). Both were aware of
which persons belonged to the study or control group, but
had no further clinical information. Thirty CT examinations
from each group were interpreted separately by RL and EK
for assessment of interobserver agreement. For those
without consensus readings, the average of the two
radiologists’ measurements were used for quantitative data,
and for qualitative assessment of whether PA was present,
cases with disagreement were resolved by reevaluation in
consensus.
Measurements and definitions
PAwas diagnosed qualitatively when there was an intrapelvic
protrusion of the medial pelvic wall at the level of the
acetabulum. The minimum thickness of the acetabular wall
was also assessed; and the term “single cortex” was applied
when only a single layer of cortical bone could be identified
on two or more contiguous 3 mm CT slices (Fig. 1).
Fig. 1 Axial CT of hips in person with MFS (a) and normal control
(b). a Bilateral protrusio acetabuli and only one cortical bone layer,
“single cortex”. b Normal hips. Single cortex in left hip (arrow)
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For quantification of PA we introduced a circle with
10 cm radius. The circle was fitted to the inner pelvic
wall at the level of the acetabulum where the cranial
border of the superior pubic ramus fuses with the
anterior column of the acetabulum (Fig. 2). This level
usually also includes the fovea of the femoral head. The
circle was adjusted to a best fit with the concavities of the
inner walls of the anterior and posterior column of the
acetabulum. The distance between the line of the circle
and the medial most point of the inner pelvic wall of the
acetabular fossa (circle-wall distance, CWD) was mea-
sured (Fig. 2). A positive distance indicates that this
medial most point is medial to the circle, and a negative
distance that the inner acetabular wall extends lateral to
the circle. Increasing degrees of PA have increasing
positive values of CWD.
Quantification of PA was also done according to the
method described by Chen et al. [1]. In compliance with
this method, the “distance between the medial most point of
the acetabular fossa and a line perpendicular to the
horizontal axis that passes through the lateral most point
of the posterior inner pelvic wall” was measured at the level
of the ischial spine. We named this distance the “fossa-line
distance” (FLD). For easier comparison of the two
methods, we decided to let positive values indicate PA, in
contrast to Chen et al. who used negative values to indicate
protrusion.
Statistics
Continuous data were described as mean and standard
deviation or median, interquartile range and range for
normally distributed or skewed data, respectively. Categor-
ical data were described as frequency and percentage.
Differences between the study groups were analyzed with
one-way ANOVA with post hoc multiple comparison using
Bonferroni correction or Pearson chi-square tests as
appropriate. Skewed data were analyzed with a non-
parametric Kruskal-Wallis test. Interobserver agreement
was evaluated with intraclass correlation coefficient for
continuous data and kappa statistics for categorical data.
Receiver operating characteristic (ROC) curves were con-
structed to assess the ability of CWD to differentiate MFS
from controls and PA from normal hips. Significance level
was set to 5%. All statistical analyses were performed by
SPSS version 16.0 (SPSS, Chicago, Il).
Results
The study population was divided into two groups through
the clinical assessment for MFS: 1) persons fulfilling the
Ghent criteria (Ghent positive, n=87), and 2) persons
suspected of having MFS, but not fulfilling the Ghent
criteria (Ghent negative, n=18). The control population
constituted the third group (n=107).
PA was diagnosed qualitatively on one or both sides in
74.7% of Ghent positive persons, in 27.8% of Ghent
negative persons, and in 3.7% of the controls (Table 2).
None of the participants were dependent on a diagnosis of
PA to become Ghent positive. PA, when present, was
bilateral in 81.5% of Ghent positive persons, in 100% of
Ghent negative persons, and in 50% of controls.
Quantitative assessment of acetabular protrusion using the
10 cm circle was possible in all study persons and controls.
Measurement of CWD showed statistically significant differ-
ences between the three groups (Table 2). The median CWD
was 3 mm (range 0.0–9.0 mm) in Ghent positive persons,
0 mm (range -0.5–5.0 mm) in Ghent negative persons, and
0 mm (range -3.0–2.0 mm) in controls. ROC analysis of
CWD vs. qualitative diagnosis of PA showed an area under
the curve of 0.99 (95% CI 0.98–1.0); a CWD cut-off value
of 1.25 mm resulted in a sensitivity and specificity for PA of
95.5% and 97.6%, respectively. ROC analysis of CWD in
differentiating MFS from controls showed a sensitivity and
specificity in diagnosing MFS of 68.8% and 97.2%,
respectively, when using a CWD cut-off value of 1.25 mm
(Fig. 3).
Measurement of acetabular protrusion according to Chen
et al. [1] was possible in 146 (68.9%) of all study persons
and controls. No statistically significant differences be-
tween the three groups were found. The median FLD was
0.0 mm (range -7.0–8.0 mm) in Ghent positive persons,
0.25 mm (range -3.0–3.0 mm) in Ghent negative persons,
and 0.0 mm (-7.0–6.0 mm) in controls.
Fig. 2 Axial CT of hips in a case of MFS with bilateral PA. A 10 cm
radius circle is adapted to the inner acetabular wall of the right hip,
and measurement of CWD is indicated. Osteoarthritis in left hip
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Statistically significant differences between women and
men were found in all three groups when using the Chen
method (Fig. 4). Median FLDs in women and men,
respectively, were 1.0 and 0.0 mm in Ghent positive
persons; 1.0 and −2.0 mm in controls. Relatively large
positive values of FLD could be found in women also in the
absence of PA (Fig. 5).
With our circle method, significant gender differences
were not found, except for the Ghent positive persons
where women had slightly larger median CWDs than men
(3.0 vs. 2.0 mm).
“Single cortex” was found on at least one side in 94.3%
of Ghent positive persons, in 83.3% of Ghent negative
persons, and in 57% of the controls. When presence of
“single cortex” was calculated as percentage of number of
hips, the figures for these three groups were 93.5%, 69.4%,
and 50.9%, respectively. These differences between the
groups were statistically significant (Table 2).
Interobserver study
The interobserver agreement for assessing PA qualitatively
was high with a kappa value (κ) of 0.88 (95% CI 0.81–
0.95) for the right hip and 0.92 (CI 0.81–1.0) for the left
hip. The circle method had an interclass correlation
coefficient (ICC) of 0.91 (95% CI 0.89–0.95) and 0.89
(95% CI 0.81–0.93) on the right and left side, respectively.
For the Chen method, ICC was 0.95 (95% CI 0.91–0.97)
and 0.94 (95% CI 0.90–0.97) on the right and left side,
respectively. The kappa value (κ) for assessment of single
cortex was 0.84 (CI 0.69–0.99) for the right hip and 0.83
(CI 0.67–0.99) for the left hip.
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Fig. 4 Boxplots showing median, interquartile distance and range of
circle-wall distance (CWD) measured with Circle method and fossa-
line distance (FLD) measured with Chen’s method [1], for males and
females, respectively
Fig. 3 ROC curve of CWD as a marker of MFS when comparing
Ghent positive patients and controls
Table 2 Characteristics of the Ghent positive persons, Ghent negative persons, and controls, in total 212 persons and 420 assessable hips
(4 total hip prostheses)
Characteristics Ghent positives Ghent negatives Controls P value
No. of hips (persons) 170 (87) 36 (18) 214 (107)
Age [mean (SD)] 39.6 (13.0) 36.1 (13.4) 39.0 (13.3) 0.592
Females [n (%)] 56 (64.4%) 11 (61.1%) 68 (63.6%) 0.966
PA qualitative method, number (percent)
of group
65 (74.7%) 5 (27.8%) 4 (3.7%) < 0.001
PA qualitative method, number (percent) of hips 116 (68.2%) 10 (27.8%) 6 (2.8%) < 0.001
Single cortex, number (percent) of hips 159 (93.5%) 25 (69.4%) 109 (50.9%) < 0.001
CWD, Circle method on hips, mm
[median (min, max)]
3.0 (0.0, 9.0) 0.0 (−0.5, 5.0) 0.0 (−3,0 2.0) < 0.001
FLD, Chen method on hips, mm [median (min, max)] 0.0 (−7.0, 8.0) n=116 0.25 (−3.0, 3.0) n=20 0.0 (−7.0, 6.0) n=144 0.322
If n is specified in a cell, the number of hips included in that measurement is different from the number included in the study. PA protrusio
acetabuli, CWD circle-wall distance, FLD fossa-line distance
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Discussion
PA is one of the manifestations that may contribute to the
diagnosis of MFS [4], however, diagnosing PA has been a
point of discussion since the accuracy of measurements on
plain pelvic radiographs is uncertain and may vary with
pelvic tilt [9]. Few authors have assessed the different
radiological methods in a validated way [9], and the
definition of PA has varied depending on the radiological
method used [8].
The reported prevalence of PA inMFS has varied in different
studies [7]. Steel et al. studied PA in children and adults with
MFS and found different percentages of PA depending on the
method of assessment; Steel´s method [12] gave 27% of the
patients the diagnosis of PAwhile the Armbuster method [13]
gave 16%. Yule et al. [6] found that 60% of their MFS
patients had PA using the relationship of the acetabular line to
the ilioischial line as the sole criterion of PA. In their study,
7% of the controls had PA based on this method.
Qualitative assessment of PA in our study was defined as
any degree of intrapelvic protrusion of the medial pelvic
wall at the level of the acetabulum. Using this criterion, we
found a very high percentage of PA in our MFS persons
(74.7%) as compared to the controls (3.7%). The finding of
PA in 27.8% of the persons suspected of having MFS but
not fulfilling the Ghent criteria, probably reflects that
several of these persons had other connective tissue
diseases that might predispose for PA. Of the 18 persons,
five had Loeys-Dietz syndrome; one vascular Ehlers-
Danlos syndrome, and one homocystinuria [11].
For quantitative assessment of differences in medial
protrusion of the acetabulum we developed the “circle
method” with a standard radius. The method was quick and
easy to apply, with a high interobserver reproducibility. We
found a 10 cm radius circle to have an arc similar to the
concavity of the inner pelvic wall at the acetabulum in most
normal adults. The vast majority of the controls therefore
had no distance between the circle and the medial pelvic
wall at this level, i.e. a CWD of 0 mm. A threshold value
for CWD with respect to PA occurs when the inner pelvic
acetabular wall is flat. The actual CWD in these cases will
vary slightly with the anteroposterior size of the acetabulum,
i.e. with the distance between the two points where the circle
crosses the acetabular wall anteriorly and posteriorly. We
found this distance to be in the order of 3–3.5 cm,
corresponding to a CWD of 1.1–1.5 mm. Our ROC analysis
suggested a cut-off value of 1.25 mm.
Measurement of CWD with our circle method confirmed
a statistically significant difference between the three
groups, PA being both more frequent and more severe in
Ghent positive persons, with a maximum CWD of 9.0 mm
as compared to 5.0 mm and 2.0 mm in Ghent negative
persons and controls, respectively. Due to the fact that
approximately 25% of the Ghent positive persons did not
have PA, CWD was not a very sensitive marker of MFS
(Fig. 3). The less than 100% specificity with the optimum
cut-off value of CWD reflects the finding that even
presumed normals may have a slight degree of PA.
The quantitative method for assessment of PA as described
by Chen et al. [1] could be applied in approximately two
thirds of the cases, the main reason for failure being
considerable asymmetry and pelvic tilt. Chen’s method
requires that the ischial spine is depicted in the same axial
image as the medial most point of the acetabular fossa, and
this was often not the case. When the method could be used,
it had a high interobserver reproducibility, but a low accuracy
in detecting PA. Somewhat unexpectedly, Chen’s method
showed significant gender differences not shown by our circle
method (except in the Ghent positive persons). This may be
explained by a difference in pelvic shape between genders.
The pelvic outlet in women tends to be wider than in men,
resulting in a higher degree of convergence of the anterior
pelvic walls. In addition, women have increased backward
sacral tilt compared to men [14], which will enhance anterior
convergence. A high anterior convergence can make the
acetabulum project medial to the inner pelvic wall of the
posterior column (Fig. 5), giving a false impression of PA.
Our circle method is not influenced by anterior conver-
gence of the pelvic walls, and the slight gender difference
in CWD found with this method in Ghent positive persons,
may therefore reflect a real difference between the sexes
with respect to development of PA in MFS.
We found bilateral PA more often in Ghent positive
persons than in the controls, probably reflecting that MFS is
a systemic disorder which is likely to affect both hips with
the same frequency.
The finding of “single cortex” for the acetabulum was
always present in cases of PA. It seems likely that the same
Fig. 5 Axial CT of the hips in female control. Relatively large FLD
(5.5 mm), but no protrusio acetabuli. Lines drawn according to
method by Chen et al [1]
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mechanism that leads to inward protrusion of the acetabular
wall also will result in thinning of the wall. “Single cortex”
was however observed also in hips without PA as more than
half of our normal controls (57%) had “single cortex” of the
acetabulum, but in a smaller part of the acetabular wall
compared to hips with PA (Fig. 1).
Our study has several limitations. The choice of a 10 cm
radius circle for measuring the degree of protrusion was
somewhat arbitrary, adjusted to the concavity of the inner
acetabular wall of most adult hips. This inner concavity is not
always uniform; the curvature of the arc may change from
anterior to posterior. In cases of PA, when the circle crosses
the inner pelvic acetabular wall at two points, the value of
CWD is not only dependent on the degree of PA, but also on
the distance between the crossing points, which again is
determined by the placement of the circle. Our interobserver
study indicates, however, that placement of the circle and
measurement of CWD could be done with high reproducibil-
ity. Using a somewhat larger circle in adults would have had
minor influence on the results. Replacing the 10 cm circle
with e.g. a 12 cm circle would have changed the threshold
values of CWD (a flat inner pelvic acetabular wall) from 1.1–
1.5 mm (see above) to 1.0–1.3 mm. A smaller circle would
have to be used for similar measurements in children. When
testing a new method for accuracy, it should ideally be
compared to an independent and established gold standard. In
this case, there was no such gold standard, and the sensitivity
and specificity of the circle method in diagnosing PA, was
therefore calculated using qualitative assessment of PA with
CT as gold standard.
CT of the hips can be performed with low radiation
dosage, but persons with hereditary connective tissue
diseases are often subject to diagnostic procedures, and
methods using ionizing radiation should be kept to a
minimum. MR imaging would probably have given similar
results with respect to assessment of PA.
Conclusions
PAwas found significantly more often in MFS persons than
in controls. Our circle method was found to be robust and
highly reproducible, giving a direct measurement of the
degree of pelvic protrusion irrespective of pelvic shape. CT
gives an excellent view of the hips, and should be preferred
to radiography in the diagnosis of PA.
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Abstract
Objectives To establish the prevalence of pulmonary artery dilatation in Marfan syndrome 
(MFS) by modern radiological methods, to correlate diameter of the vessel with aortic 
disease, and explore predictors of pulmonary artery dilatation in MFS.
Methods MR or CT imaging of the pulmonary artery and aorta was performed in 87 patients 
with proven MFS. Diameters of the pulmonary artery root and trunk, and of the aortic root 
were measured perpendicular to the long axis of the vessels; pulmonary artery diameters on
axial images, and aortic diameters on oblique sagittal images.
Results Compared to normal values in the literature, 47 of the 87 patients (54%) had widened 
pulmonary artery trunk (PP2IWKHVHKDGQRVLJQRIDVFHQGLQJDRUWLFGLVHDVH
The mean (SD) ratio between pulmonary artery root and trunk diameters was 1.18 (0.155). 
Multivariate analysis showed that ascending aortic surgery and high BSA were associated 
with dilatation of the pulmonary artery trunk.
Conclusions Pulmonary artery dilatation is found in a high proportion of MFS patients, and 
should be assessed using cut-off values based on pulmonary artery diameter measurements in 
the normal population. Severe disease of the ascending aorta is a significant predictor of 
pulmonary artery trunk dilatation in MFS patients.
Keywords
Pulmonary artery, aorta, MR imaging, connective tissue disease, Marfan syndrome
3 
 
Introduction
Marfan syndrome (MFS) is an autosomal dominant genetic connective tissue disorder 
characterized by manifestations in many organ systems, stated in the Ghent criteria from 1996 
(“Ghent 1 criteria”) [1]. The diagnosis is based on findings in skeleton, eyes, the 
cardiovascular and pulmonary systems, the skin and integument, dura, a family history, and 
mutations in the gene encoding for fibrillin one (FBN1) [1, 2]. A major and frequent 
cardiovascular criterion of MFS is dilatation of the ascending aorta and aortic root. To fulfil 
the major cardiovascular criterion in the Ghent nosology, the aortic root and/or ascending 
aorta must be affected.
According to the Ghent nosology from 1996 “dilatation of the main pulmonary artery, in the 
absence of valvular or peripheral pulmonary stenosis or any other obvious cause, below the 
age of 40 years” is considered a minor cardiovascular criterion of MFS [1]. Although 
dilatation of the aortic root and pulmonary artery often are coexistent [3], it has been 
suggested that pulmonary artery dilatation may be a sign of cardiovascular involvement in 
MFS patients even in the absence of aortic disease [3].
Dilatation of the pulmonary artery is described as a sign of MFS in many articles [1, 3-7], but 
documentation of the proportion of patients with dilated pulmonary artery in the MFS 
population with modern radiological methods, is sparse. Revised Ghent criteria were 
published in 2010 (“Ghent 2 criteria”) [8], and here dilatation of the pulmonary artery is not 
included. Lack of specificity and incomplete knowledge of threshold values for dilatation of 
the pulmonary artery are among the reasons for excluding dilatation of this structure from the 
Ghent criteria. Further research was recommended.
In the present study, the axial diameters of the pulmonary artery root and trunk and the 
oblique sagittal diameter of the aortic root were measured with MR imaging or CT in a cohort 
of 87 patients with proven MFS without other known causes of pulmonary artery dilatation. 
Measurements were compared to normal values based on MR and CT in the literature. The 
aims were to find the prevalence of dilated pulmonary artery in MFS, to correlate diameters of 
the vessel with aortic disease, and to explore predictors of pulmonary artery dilatation in 
MFS.
 
Materials & Methods
The study was approved by the regional medical ethics committee; and for the purpose of 
informed consent, only patients older than 18 years of age were included. 
None of the patients were suspected of having pulmonary hypertension. 
4 
 
Study population 
The participants were recruited either by letter sent to the 134 individuals above 18 years of 
age registered in a National resource centre as having MFS; by advertisement in the journal of 
the National Association of MFS, or through invitations distributed in the Department of
Thoracic and Cardiovascular Surgery at our hospital to patients suspected of having MFS. 
Age was the only exclusion criterion before the examinations. Out of 109 individuals that 
gave informed consent for participation, one died before the study started; one living abroad 
was not able to attend, and two withdrew. All 105 participants were Caucasian. All patients 
were assessed for all parts of the Ghent criteria (Ghent 1) [1] by the same group of physicians. 
For assessment of fulfilment of the major cardiovascular criterion in the Ghent nosology, 
information about previous surgery due to dilatation or dissection of the ascending aorta, and 
dilatation of the ascending aorta measured with echocardiography was used [1, 9].The 
assessment of Ghent criteria included sequencing of the entire coding region of the gene 
FBN1 and search for large deletions or duplications [9].
MR or CT of the aorta and pulmonary artery
This study was a substudy of the “Norwegian Marfan Study”. In this part of the study MR 
imaging of the aorta and the pulmonary artery was performed unless contraindicated when CT 
examinations were obtained instead.
MR imaging at 1.5 T (Signa LX, GE Healthcare, Milwaukee, Wisconsin) of the aorta and 
pulmonary artery in axial and oblique sagittal planes was performed using a standard ECG-
gated T1-weighted SE sequence. Repetition time equalled the R–R interval, echo time was 
minimum 9.32 ms to maximum 39.976 ms, slice thickness was 7 mm in the axial plane, and 4 
mm in the oblique sagittal plane. 
Non-enhanced axial CT images with 5 mm slice thickness were obtained on a ProSpeed SX 
scanner (GE Healthcare, Milwaukee, Wisconsin) in patients in whom MRI was 
contraindicated. As part of assessment of all Ghent criteria, HRCT of the lungs was 
performed as well. 
Measurements and estimations
Consensus readings were performed by two radiologists (HJS and RL) of all MR and CT 
examinations. Aortic dimensions were assessed perpendicular to the long axis of the vessel on
oblique sagittal images at the level of the sinuses of Valsalva (aortic root). Main pulmonary 
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artery dimensions were assessed perpendicular to the long axis of the artery on axial images at 
two levels: the pulmonary artery root, and the pulmonary artery trunk at the pulmonary artery 
bifurcation (Fig. 1). 
Figure 1. Axial MR images of 63-year-old male MFS patient. Diameter measurement of the pulmonary artery 
trunk (a) and pulmonary artery root (b) is indicated. The ascending aorta is replaced by a graft.
In the present substudy, fulfilment of the major cardiovascular criterion for MFS was 
reassessed using MR or CT measurements of all native ascending aortas. The aortic root 
diameter and body surface area (BSA) for each participant were plotted in Roman et al.´s 
nomogram [1, 10].
This major criterion was also considered fulfilled in participants having previous surgery on 
the ascending aorta due to dilatation or dissection.   
Assessment of pulmonary artery dilatation (root and trunk) according to Ghent 1 criteria was 
performed using nomograms for the aortic root [1]. Pulmonary artery trunk dilatation was 
reassessed by comparison with recently published data on normal values based on 5 mm axial 
CT imaging, suggesting a mean diameter of 24.0 mm and an upper limit of 29.6 mm (24.0 
mm + 2 SD) for the normal pulmonary artery trunk in adults [11]. Using an electronic calliper 
with 1 mm increments, we defined pulmonary trunk dilatation as diameters PPLQRXU
reassessment.
Statistics
Data were described as mean (standard deviation) or frequency (percentage) for continuous or
categorical variables, respectively. Univariate statistical analysis on differences between 
groups were analysed with independent sample t-test or chi-square, as appropriate, and 
correlation assessed with Pearson correlation coefficient. Multivariate analysis on factors 
influencing pulmonary artery diameter was done with a multiple linear model. The statistical 
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level of significance was 5%. All analyses were conducted with SPSS version 18 (SPSS Inc, 
Chicago, IL).
Results
Eighty-seven out of 105 persons (56 female) fulfilled the Ghent 1 criteria for MFS, and in the 
present substudy of a national Marfan Study, these 87 persons constituted the study group. 
The mean (SD) age in men were 35.1 (11.1) years, and in female 42.1 (13.5) years. 
Characteristics of the study population are given in Table 1.
Table 1. Characteristics of study population given as mean (SD) or number of patients (percentage). 
Diameters measured by MR or CT.
Patient characteristics
Number of patients 87
Female 56 (64.4%)
Age (years) 39.6 (13.0)
Weight (kg) 82.7 (17.3)
Height (cm) 184.2 (10.6)
BSA (m2) 2.07 (0.24) 
BMI (kg/cm2) 24.7(4.38)
Diameter of aortic roots (mm) without previous aortic surgery, n=56 36.6 (6.9)
Patients with previous surgery on ascending aorta 30 (34.5%)
Pulmonary artery root diameter (mm), n=86 35.0 (4.6)
Pulmonary artery trunk diameter (mm) 29.8 (3.8)
Pulmonary artery trunks widened according to Ghent 1 criteria (1996) 0
Pulmonary artery roots widened according to Ghent 1 criteria (1996) 7
Pulmonary artery trunks widened according to cut-off 30 mm 47 (54%)
Pulmonary artery roots widened according to cut-off 34.8 mm, n=86 43 (50%)
MR imaging was contraindicated in six persons, and CT was therefore performed instead. In 
five of the 81 thoracic MR examinations of the study group, image quality was inadequate for 
measurement of pulmonary artery dimensions; in these five cases HRCT was available for 
diameter measurements. In one of the 87 patients neither MR nor CT had adequate depiction 
of the pulmonary artery root, and the diameter could therefore not be measured.
MR and CT measurements of the pulmonary artery showed mean (SD) diameters of the 
pulmonary artery root and trunk of 35.0 (4.6) mm and 29.8 (3.8) mm, respectively. The 
pulmonary artery root was found to have larger diameter than the trunk in most cases, and the 
mean (SD, range) ratio between the pulmonary artery root and trunk was 1.18 (0.155, 0.78-
1.58).
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According to Ghent 1 criteria for pulmonary artery dilatation [1], which are based on 
nomograms of the aortic root, 7 out of 39 patients (17.9%) under 40 years of age had dilated 
pulmonary artery root, while none had dilatation of the pulmonary artery trunk. Compared to 
published  normal values for adult pulmonary artery trunk diameters [11], 47 (54%) of the 87 
patients had dilated pulmonary artery trunk with a diameter PP
Thirty (34.5 %) of the 87 persons had previous surgery on the ascending aorta. 
Echocardiographic measurements in the remaining 57 patients showed that 16 of these 
patients had dilated aortic root according to the Ghent 1 criteria (nomograms by Roman et al.) 
[9], however, when the aortic root diameters were reassessed with MR or CT, 40 of the 57 
aortic roots were found to be dilated. Based on MR or CT a total of 70 (80.5%) patients thus 
fulfilled the major cardiovascular criterion for MFS. The MR or CT measured mean (SD) 
aortic root diameter in the 57 patients with native ascending aorta was 41.3 (6.1) mm.
Seven (14.9%) of the 47 patients with pulmonary artery trunk diameter PPKDGQRUPDO
diameter of the aortic root, 20 (42.6%) had a dilated native aortic root, and 20 (42.6%) had 
previous surgery on the ascending aorta.
Table 2. Pulmonary artery diameters in relation to patient characteristics.
Diameter of 
pulmonary artery 
root, n = 86
p-value 
pulmonary 
artery root
Diameter of 
pulmonary artery 
trunk, n = 87
p-value 
pulmonary 
artery trunk
Gender, mean (SD) mm
Male
Female
36.2 (4.2)
34.4 (4.7)
0.063 29.9 (3.1)
29.8 (4.2)
0.932
Age, correlation 0.300 0.005 0.182 0.091
Height, correlation 0.261 0.015 0.147 0.173
Weight, correlation 0.425 < 0.001 0.353 0.001
BMI, correlation 0.265 0.014 0.185 0.086
BSA, correlation 0.385 < 0.001 0.285 0.007
Previous surgery ascending aorta, 
mean (SD) mm
Yes
No
36.5 (5.1) 
34.2 (4.1)
0.035 31.32 (4.7)
29.0 (3.0)
0.017
There were no significant differences between genders with respect to pulmonary artery 
diameters, but a tendency towards larger pulmonary artery root diameters in men (p=0.063) 
(Table 2). The pulmonary artery root diameters correlated significantly with age, height, 
weight, BMI and BSA, while the pulmonary artery trunk diameters had significant positive 
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correlation with weight and BSA only (Table 2). Pulmonary artery root and trunk diameters 
were significantly larger in patients with previous surgery on the ascending aorta compared to 
those without such surgery (p=0.041 and p=0.027, respectively) (Table 2). Pulmonary artery 
trunk diameters were significantly larger in patients with ascending aortic disease (dilatation 
or previous surgery) than in those without (p=0.018), but the pulmonary artery root diameters 
were not significantly larger in this patient group (p=0.104).
A multivariate analysis of variables that potentially may have influenced the pulmonary artery 
root and trunk diameters is shown in Table 3. For the pulmonary artery root, age (p=0.009) 
and BSA (p=0.028) were the only parameters which correlated significantly with the vessel 
diameter. Previous surgery on the ascending aorta (p=0.005) and BSA (p=0.004) correlated 
significantly with the pulmonary artery trunk diameter.
Table 3. Multivariate analysis of variables that might affect pulmonary artery diameters. 
A. Dependent variable: diameter of pulmonary artery root
Parameter Coeffient (95% CI) p-value
Ascending aorta
Dilated 0.73 (-1.68; 3.15) 0.55
Previous surgery 2.00 (-0.54; 4.54) 0.12
Male gender 0.77 (-1.67; 3.22) 0.53
Age 0.098 (0.025; 0.17) 0.009
BSA 5.38 (0.60; 10.16) 0.028
BMI 0.13 (-0.098; 0.35) 0.27
B. Dependent variable: diameter of the pulmonary artery trunk.
Parameter Coeffient (95% CI) p-value
Ascending aorta
Dilated 1.68 (-0.42;  3.77) 0.12
Previous surgery 3.18 (-0.97; 5.39) 0.005
Male gender -1.96 (-4.08; 0.16) 0.07
Age 0.02 (-0.04; 0.09) 0.48
BSA 6.2 (2.03; 10.36) 0.004
BMI 0.017 (-0.18; 0.21) 0.86
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Discussion
Our study showed that when compared to normal values in healthy adult persons [11], more 
than half (54%) of our adult patients with proven MFS had dilatation of the pulmonary artery 
trunk, some (approx. 15%) even in the absence of dilatation of the aortic root or ascending 
aorta.
The Ghent 1 criteria of 1996 [1] included dilatation of the pulmonary artery as a sign (minor 
vascular criterion) of MFS, but in the revised criteria (Ghent 2) published in 2010 [8], this 
criterion was omitted. Reasons given were that pulmonary artery dilatation is not specific to 
the diagnosis of MFS, that complications of pulmonary artery disease are rarely seen, and that 
further research is needed regarding thresholds and the diagnostic utility of this finding [8] .
The uncertainty regarding threshold values for pulmonary artery dilatation is partly caused by 
the vagueness of the Ghent 1 criteria with respect to the pulmonary artery. The authors state 
that “until normal values for pulmonary artery diameter are available, dilatation can be 
detected provisionally by echocardiography, CT or MRI using nomograms for the aorta” [1].
Furthermore, the Ghent 1 criteria do not specify which part of the pulmonary artery should be 
measured, the root or the trunk.
In our study of 87 MFS patients, we measured the pulmonary artery root and trunk diameters 
on axial 7 mm or 5 mm slices based on MR (7 mm) or CT (5 mm). In the literature, most 
papers addressing upper normal values for the pulmonary artery have considered the 
pulmonary artery trunk only, and among those performed with axial imaging [4, 11-14], only 
three have included an adequate number of subjects (Table 4). The upper normal limit for the 
pulmonary artery trunk diameter, defined as mean diameter + 2 SD, was quite similar in two 
of the studies [12, 13], 32.4 and 33.2 mm, respectively, and clearly larger than in the third 
study [11], 29.6 mm. This may be explained by the difference in slice thickness, 10 mm vs. 5 
mm. axial slices will cut the main pulmonary artery obliquely, and thicker slices are apt to 
overestimate the diameter due to partial volume effects. The 126 subjects studied by Bozlar et 
al. [11] were imaged with nearly the same slice thickness as our MFS patients, and the age 
distribution was furthermore similar, 30.6 ± 7.9 years and 35.1 ± 11 years, respectively. 
Pulmonary hypertension and thoracic pathology had been excluded. We therefore consider 
this group of healthy adults as an adequate control group for our study.
10 
 
Table 4. Literature review of normal pulmonary artery (PA) trunk diameters based on axial CT or MR 
imaging.
Reference Subjects 
(n)
Age, mean 
(SD) years
Modality /
slice thickness
PA trunk diam.
mean ± SD mm
PA trunk 
upper limit, 
mean + 2SD
Karazincir et 
al. 2008 (13)
112 46.3 ± 13.6 CT / 10 mm 26.6 ± 2.9 32.4
Bozlar et al. 
2007 (11) 
126 30.6 ± 7.9 CT / 5 mm 24.0 ± 2.8 29.6
Nollen et al. 
2002 (4)
15 28.0 ± 4.0 MR / unknown 24.0 ± 2.0 28.0
Choe at al. 
2000 (14)
10 Unknown, 
range 25-72
CT / 10 mm 25.6 ± 2.2 30.0
Edwards et al. 
1998 (12)
100 Unknown, 
range 11-90
CT / 10 mm 27.2 ± 3.0 33.2
Normal values for the pulmonary artery root diameter are nearly non-existing in the literature.
Nollen et al. measured diameters of the pulmonary artery root and trunk in 50 MFS patients 
and 15 controls using MR imaging. Their pulmonary artery root diameters were not 
perpendicular to the long axis of the vessel, however, instead three separate oblique diameters 
in the axial plane were measured, and the anterior right diameter was used for analysis [4].
They suggested an upper normal value for the pulmonary artery root of 34.8 mm based on this 
diameter. Using this cut-off value, 50% (43 of 86) of our MFS patients had dilated pulmonary 
artery root (Table 1). The pulmonary artery root diameter in MFS patients and controls has 
also been assessed with echocardiography, and based on ROC analysis, a cut-off value for 
discriminating between normals and MFS of 23 mm was suggested for subjects older than 14 
years [3]. This is clearly a much smaller value than the upper limit suggested by Nollen et al. 
[4] (34.8 mm) and the mean value in our MFS patients (35.0 mm), probably reflecting the 
inherent differences between the modalities used. Measurements comparable to those 
obtained with axial CT or MR imaging may be difficult to obtain with echocardiography 
where the imaging plane is dependent on the acoustic window. This difficulty is underscored 
by our own study. Our preliminary measurements of aortic root diameters were performed 
with echocardiography and resulted in 16 out of 57 MFS patients having dilated aortic root. 
When remeasured with MR or CT, the number increased to 40 of 57.
The large discrepancy between the findings of pulmonary artery dilatation using nomograms 
for the aorta as recommended by Ghent 1 [1] and when using cut-off values based on 2 SD 
above the mean value in healthy volunteers, suggests that nomograms for the aorta are not 
suited for assessment of pulmonary artery dilatation. In the normal population, the pulmonary 
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artery trunk is on average smaller than the ascending aorta, but the variation is large. In a 
recent multidetector CT study of 103 normal, healthy adults, the ratio of short axis pulmonary 
trunk diameter to short axis ascending aorta was mean (SD) 0.89 (0.24) [15].
The aortic and pulmonary artery roots have a common embryologic origin [16], and since 
aortic root dilatation is typical of MFS, it has been speculated that the pulmonary artery root is 
the most likely part of the vessel to dilate [3, 4]. There is sparse evidence only of this in the 
literature. In an MR study of 50 adult MFS patients and 15 adult controls [4], the pulmonary 
artery root was found to be wider than the pulmonary artery trunk in both patients and 
controls; the difference between root and trunk was, however, larger in MFS patients than in 
controls [4]. The pulmonary artery root being wider than the trunk is confirmed by our own 
study, mean (SD) diameters being 35.0 (4.6) and 29.8 (3.8), respectively.
The above findings and speculations could indicate that pulmonary artery root dilatation is 
more strongly correlated to disease of the ascending aorta in MFS patients than is pulmonary 
artery trunk dilatation. This was not confirmed by our study. Both the pulmonary artery root 
and trunk were significantly larger in the patients with previous surgery on the ascending 
aorta than in those without previous surgery, probably reflecting a correlation between 
pulmonary artery dilatation and the most severe cases of aortic disease in MFS. However, 
when comparing pulmonary artery diameters in patients fulfilling the major cardiovascular 
criterion (surgery or dilatation of the aortic root or ascending aorta) and those not fulfilling the 
criterion, only the pulmonary artery trunk was significantly larger in patients fulfilling the 
criterion. A correlation between aortic disease and pulmonary artery trunk diameter was also 
suggested by our multivariate analysis showing that previous surgery on the ascending aorta 
was a significant predictor of pulmonary artery trunk dilatation, but not of pulmonary artery 
root dilatation.
Although a large majority of the patients with dilated pulmonary artery trunk also had aortic 
disease (40 out of 47 or 85.1%), a few of these patients (7 out of 47, 14.9%) had no sign of 
ascending aortic disease, suggesting that pulmonary artery dilatation may be an early marker 
of vascular disease in MFS patients.   
The clinical implications of our findings are few, but important. Pulmonary artery trunk 
dilatation is common in MFS patients, and does not by itself imply pulmonary hypertension. 
Dilatation of this vessel in a MFS patient may suggest MFS-related vascular affection even in 
the absence of visible ascending aortic disease.
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Limitations
A major limitation of our study is lack of controls using the exact same imaging technique as 
for our patients. Some relevant and high quality studies of healthy adults using similar 
technique as ours have been published, however, and we believe that normal values for 
pulmonary artery trunk diameter using axial imaging are now well documented [11]. Reliable 
normal values for pulmonary artery root diameter are still missing, however, and may be 
difficult to obtain given the asymmetry of this part of the vessel.
Our study was performed in the period 2002 – 2004, and MR techniques for non-enhanced 
imaging of thoracic vessels have improved since then. Multi-slice ECG-triggered MR 
imaging also introduces a small variation in vessel diameter due to imaging of the vessel at 
different time points during the cardiac cycle. 
Conclusions
Pulmonary artery dilatation is a common finding in MFS (54%), and should be assessed using 
cut-off values based on pulmonary artery diameter measurements in the normal population, 
not on nomograms intended for the aorta. MR or CT imaging seems to provide more reliable 
results for pulmonary artery dimensions than echocardiography. Severe disease of the 
ascending aorta is a significant predictor of pulmonary artery trunk dilatation in MFS patients, 
but such dilatation may occur even in the absence of visible aortic disease.     
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